WO2021249545A1 - Method for one-step preparation of polyether having trans-fused polycyclic ether framework structure - Google Patents

Method for one-step preparation of polyether having trans-fused polycyclic ether framework structure Download PDF

Info

Publication number
WO2021249545A1
WO2021249545A1 PCT/CN2021/099762 CN2021099762W WO2021249545A1 WO 2021249545 A1 WO2021249545 A1 WO 2021249545A1 CN 2021099762 W CN2021099762 W CN 2021099762W WO 2021249545 A1 WO2021249545 A1 WO 2021249545A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
formula
trans
carbon atom
fused polycyclic
Prior art date
Application number
PCT/CN2021/099762
Other languages
French (fr)
Chinese (zh)
Inventor
渠瑾
李风兴
Original Assignee
南开大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南开大学 filed Critical 南开大学
Publication of WO2021249545A1 publication Critical patent/WO2021249545A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the invention relates to a one-step method for preparing a polyether with a trans-fused polycyclic ether skeleton structure.
  • the cyclic ether (the size of the cyclic ether is five-membered cyclic ether, six-membered cyclic ether, seven-membered cyclic ether, eight-membered cyclic ether, and nine-membered cyclic ether). Because it contains multiple fused cyclic ethers, marine polyether toxins The molecular skeleton of the product is in the shape of a ladder, so it is also known as a trapezoidal thick polyether toxin.
  • Marine polyether toxins produced by marine algae generally have strong neurotoxicity. When marine algae multiply morbidly, the marine polyether toxins produced by them can cause a large number of deaths of marine organisms. Marine polyether toxins can also be concentrated in fish, shrimp or shellfish through the transmission of the food chain. If the contaminated fish, shrimp or shellfish is accidentally eaten by humans, it will cause a poisoning reaction, which can lead to death in severe cases (Toxicon 2001, 39). , Pp 97-106). But there are also some marine polyethers that have biological activity that can be developed as drugs (Chem. Res. Toxicol. 2004, 17, pp 1251-1257).
  • brevenal can also competitively bind to the protein receptors of breven pyridine toxin and ciguatoxin in the human body, thereby reducing the poisoning reaction caused by breven pyridine toxin and ciguatoxin (Cell.Mol .Neurobiol. 2004, 24, pp 553-563).
  • brevenal is a potential treatment option for chronic lung diseases such as cystic fibrosis
  • the daily use of brevenal or its derivatives will be very expensive for patients.
  • the content of brevenal produced by Lusoflagellate is very low, and it is difficult to obtain large amounts of brevenal only by extraction.
  • the brevenal containing the trans-fused 7/7/6/7/6 pentacyclic ether structure can also be obtained by artificial synthesis.
  • the total yield of total synthesis of 57 steps is 0.84% (Figure b, Org. Lett. 2009, 11, pp 2531-2534); In 2010, the second-generation total synthesis route of Professor Kadota’s research group required 53 steps, with a total yield of 1.8% (Tetrahedron 2010, 66, pp 5329-5344) ; In 2011, Professor Rainier's research group from the University of Utah used the key enester cyclization reaction to achieve the construction of the two-ring CD of brevenal. Their total synthesis route of brevenal was 38 steps, and the total yield was 0.99% (Figure c below) , J. Am. Chem. Soc. 2011, 133, pp 3208-3216).
  • long-chain polyepoxy compounds can be synthesized from long-chain polyene compounds by Shi asymmetric epoxidation in one step, and long-chain polyene compounds can be synthesized from commercially available small molecules.
  • the raw materials are prepared by organic reactions such as Wittig reaction and transition metal-catalyzed coupling reaction, so the precursor compound of the tandem reaction is easy to prepare in organic synthesis, but it is a one-step series connection of long-chain homochiral polyepoxy precursors.
  • the trans-fused polycyclic ether can be constructed through the intramolecular endo, endo-selective series epoxy ring-opening and cyclization reaction of the polyepoxy precursor compound. structure.
  • the Murai research group in Japan developed the intramolecular endo, endo-selective tandem epoxy ring-opening and cyclization reaction of homochiral polyepoxy precursor compounds catalyzed by lanthanum salt.
  • the McDonald research group in the United States found that when the homochiral polyepoxy precursor compound has a carbonyl group instead of a hydroxyl group as the terminating group, the polyepoxy precursor compound can undergo intramolecular endo, endo-selection under the catalysis of Lewis acid.
  • the serial epoxy ring-opening and cyclization reaction realizes the construction of polyethers in which all the trans-fused cyclic ethers are seven-membered rings.
  • the yield of polyethers containing four seven-membered rings is only 12% (J. Org. Chem. 2002, 67, pp 2515-2523).
  • the yields of the first two cases of these 3 cases are low, and these 3 cases can only produce all six-membered ring polyethers or all seven-membered ring polyethers, while the biologically active marine polyether toxin brevenal molecule It has a 7/7/6/7/6 five-ring structure mixed with six-membered cyclic ether and seven-membered cyclic ether.
  • many biologically active marine polyether toxins contain eight-membered cyclic ethers or nine-membered cyclic ethers.
  • the existing endo, endo-selective tandem epoxy ring-opening and cyclization method cannot be used to synthesize molecules containing eight-membered cyclic ethers. Cyclic ethers or polyethers of nine-membered cyclic ethers.
  • the technical problem to be solved by the present invention is that the preparation method of polyether with trans-fused polycyclic ether skeleton structure in the prior art is relatively simple, thereby providing a new one-step method for preparing polyether with trans-fused polycyclic ether skeleton Structured polyether (trans-fused polycyclic polyether) method.
  • This method uses easy-to-prepare long-chain homochiral polyepoxy compounds as raw materials, and can synthesize trans-fused polycyclic ether compounds through a one-step intramolecular endo, endo-selective serial epoxy ring-opening and cyclization reaction.
  • the cyclic ether in the formed polycyclic ether compound may be a six-membered cyclic ether, a seven-membered cyclic ether, an eight-membered cyclic ether, a nine-membered cyclic ether, or a combination thereof.
  • the present invention provides a method for preparing a trans-fused polycyclic ether compound represented by formula (I), which comprises the following steps: in the presence of a reaction medium and a salt containing a weak coordination anion, the formula (II)
  • the homochiral polyepoxy compound shown is prepared by a one-step cyclization reaction to obtain the trans-fused polycyclic ether compound represented by formula (I);
  • Each R is the same or different, and is independently selected from H, C 1-3 alkyl- or halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl or isopropyl; most preferably H Or methyl
  • Each R 1 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H. Methyl;
  • Each R 2 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H, methyl; or, when R 2 is connected to a double-bonded carbon atom, R 2 does not exist;
  • n is the same or different, and is independently selected from 1, 2, 3, 4;
  • the carbon atoms in the fragments can be optionally substituted by the following groups: H, OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-;
  • R 3 is H or an acid-sensitive hydroxyl protecting group
  • the acid-sensitive hydroxyl protecting group is for example an ether protecting group (such as THP (2-tetrahydropyranyl)), a silyl ether protecting group (such as TMS (three Methylsilyl) or TES (triethylsilyl)), preferably THP, TMS, most preferably THP;
  • the part represents the structure in which the x fragments and the y fragments appear alternately and repeatedly.
  • the structures of the trans-fused polycyclic ether compound and the homochiral polyepoxy compound are defined as follows:
  • each R is the same or different, and is independently selected from H, C 1-3 alkyl-, halogenated C 1-3 alkane Group -; H, methyl, ethyl, propyl, isopropyl are particularly preferred; H, methyl is most preferred.
  • Each R 1 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H. Methyl;
  • Each R 2 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H, methyl; or, when R 2 is connected to a double-bonded carbon atom, R 2 does not exist;
  • n is the same or different, and is independently selected from 1, 2, 3; or
  • the carbon atoms in the fragment can be optionally substituted by the following groups: H, OH, C 1-4 alkyl-, halo C 1-4 alkyl-; or
  • the Structure is (I.e. form with the structure on the right ), where the a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
  • the structure is the same or different, which are independently The c terminal is connected to the left group, and the d terminal is connected to the right group;
  • Each hydrogen atom in the structure is independently optionally substituted by R 4 ;
  • R 4 is independently OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-, preferably methyl, ethyl, propyl , Isopropyl, most preferably methyl.
  • each n is the same or different, and is independently selected from 1, 2 or 3. .
  • R 3 is H.
  • R 3 is an acid-sensitive hydroxyl protecting group, such as an ether protecting group
  • the group for example, THP (2-tetrahydropyranyl)
  • the silyl ether protecting group for example, TMS (trimethylsilyl) or TES (triethylsilyl)
  • THP 2,3-tetrahydropyranyl
  • TMS trimethylsilyl
  • TES triethylsilyl
  • the R connected to the carbon atom marked with * is a C 1-3 alkane Group-, preferably methyl, ethyl, propyl, isopropyl, most preferably methyl.
  • R 1 connected to the carbon atom marked with * is C 1-10 Alkyl-, preferably C 1-6 alkyl-, more preferably C 1-3 alkyl-, particularly preferably methyl, ethyl, propyl, isopropyl, and most preferably methyl.
  • R and R 1 connected to the carbon atom marked with * are the same .
  • R and R 1 connected to the carbon atom marked with * are both methyl base.
  • R in the u, v, x, and y fragments are independently H Or C 1-3 alkyl-, particularly preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl.
  • the Structure in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, the Structure is The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others The structure is the same or different, which are independently Above Each hydrogen atom in the structure is independently optionally substituted by R 4.
  • the Structure in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, the Structure is The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others The structure is the same or different, which are independently Above Each hydrogen atom in the structure is independently optionally substituted by R 4.
  • the leftmost compound of the general formula structure above Each hydrogen atom in the structure is independently optionally substituted by R 4 ; R 4 is independently OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-, preferably C 1-3 alkyl-, Particularly preferred are methyl, ethyl, propyl, and isopropyl, and most preferred are OH and methyl.
  • the leftmost compound of the general formula Structure is
  • R 2 is H or C 1-10 alkyl-, preferably H Or C 1-6 alkyl-, more preferably H or C 1-3 alkyl-, particularly preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl; or, & marked When a double bond is connected to the carbon atom, R 2 connected to the carbon atom marked with & does not exist.
  • R 2 connected to the carbon atom labeled & is H, or, When a double bond is connected to the carbon atom labeled &, R 2 connected to the carbon atom labeled & does not exist.
  • the R connected to the carbon atom labeled & is H or C 1- 3 Alkyl-, preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl, such as H.
  • R 2 and R connected to the carbon atom labeled & are H, Alternatively, when a double bond is connected to the carbon atom labeled &, R 2 connected to the carbon atom labeled & does not exist.
  • the R connected to the carbon atom marked with # is H or C 1- 3 Alkyl-, preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl.
  • R 2 connected to the carbon atom marked with # is H or C 1 -10 alkyl-, preferably H or C 1-6 alkyl-, more preferably H or C 1-3 alkyl-, particularly preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl.
  • R 2 and R connected to the carbon atom labeled with # are the same .
  • R 2 and R connected to the carbon atom labeled with # are the same And is H or methyl.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , and n are defined as described in any of the above schemes.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes;
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , and n are as defined above.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes;
  • the structure is independently
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , and n are as described in any of the above schemes.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes;
  • the structure is independently
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes;
  • the structure is independently
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , and n are defined as described in any of the above schemes.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes.
  • the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
  • R, R 1 , R 2 , R 3 , n The definition is as described in any of the above schemes;
  • the structure is independently
  • R in the u, v, x and y fragments are independently H or methyl
  • the a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
  • the structure is the same or different, which are independently
  • R 2 and R connected to the carbon atom marked with # are the same and are H or methyl;
  • R 2 connected to the carbon atom labeled & is H, or when a double bond is connected to the carbon atom labeled &, R 2 connected to the carbon atom labeled & does not exist.
  • the structure of the trans-fused polycyclic ether compound and the polyepoxy compound is any one of the following groups:
  • the reaction medium may be a C 1-10 alkyl alcohol substituted by one or more halogens or its Mixed solvent with other solvents.
  • the C 1-10 alkyl alcohol substituted by one or more halogens is preferably C 1-8 alkyl alcohol substituted by one or more halogens , more preferably C 1 substituted by one or more halogens.
  • the other solvent may be selected from C 1-10 alkanes substituted with one or more halogens, C 1-10 ethers or cyclic ethers optionally substituted with one or more halogens, C 1-10 optionally substituted with one or more halogens 1-10 esters; preferably chloroform, dichloromethane, 1,2-dichloroethane, 1,1-dichloroethane ethyl ether, tetrahydrofuran, 1,4-dioxane.
  • the reaction medium is most preferably trifluoromethanol, trifluoroethanol, perfluoroethanol, trifluoropropanol (Including n-propanol, isopropanol), hexafluoropropanol (including n-propanol, isopropanol), perfluoropropanol (including n-propanol, isopropanol), trifluorobutanol (including n-butanol) , Isobutanol, tert-butanol), hexafluorobutanol (including n-butanol, isobutanol, tert-butanol), perfluorobutanol (including n-butanol, isobutanol, tert-butanol), trifluorobutanol Pentanol,
  • the reaction medium may specifically be 2,2,2-trifluoroethanol (TFE), 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), perfluoro tertiary Butanol (PFTB), most preferably perfluoro-tert-butanol (PFTB).
  • TFE 2,2,2-trifluoroethanol
  • HFIP 1,1,1,3,3,3-hexafluoro-2-propanol
  • PFTB perfluoro tertiary Butanol
  • PFTB perfluoro-tert-butanol
  • the weakly coordinating anion-containing salt is soluble in the reaction medium.
  • the anionic salt containing weakly coordinating anion is preferably a fluorine-containing weakly coordinating anion, it may be: tetrafluoroborate anion (BF 4 -), hexafluorophosphate anion (PF 6 -), six hexafluoro antimonate anion (SbF 6 -), trifluoromethanesulfonic acid anion (trifluoromethansulfonate, TfO-), tetrakis [3,5-bis (trifluoromethyl) phenyl] borate anion (tetrakis [3,5-bis ( trifluoromethyl) phenyl] borate, (BARF )), tetrakis (pentafluorophenyl) borate anion (tetrakis (pentafluorophenyl) borate); preferably tetrafluoroborate anion (BF 4 -), hexafluorophosphate anion (PF 6 -), he
  • the cation of the salt containing weak coordination anion can be selected from quaternary ammonium ion or quaternary phosphorus ion, for example, tetramethylammonium ion (Me 4 N + ), tetraethylammonium ion (Et 4 N + ), tetra-n-butylammonium ion ((n-Bu) 4 N + ), tetraphenyl quaternary phosphonium ion (Ph 4 P + ), 1-butyl-3-methylimidazole quaternary ammonium ion ([BMIM]) , 1-ethyl-3-methylimidazole quaternary ammonium ion ([EMIM]), 1-hexyl-3-methylimidazole quaternary ammonium ion ([HMIM]); preferably 1-butyl-3-methylimidazole quaternary Ammonium ion ([BMIM]),
  • the salt containing weak coordination anions may specifically be [BMIM]BF 4 , [BMIM]PF 6 , [EMIM]BF 4 , [EMIM]PF 6 , [HMIM]BF 4 , [HMIM ]PF 6 ; preferably [BMIM]BF 4 , [EMIM]BF 4 , [HMIM]BF 4 ; more preferably [EMIM]BF 4 .
  • the molar ratio of the salt containing the weakly coordinating anion to the homochiral polyepoxy compound represented by formula (II) may be 1:10-10:1, preferably 1:5-5:1, It is more preferably 1:2 to 2:1, most preferably 1:1.
  • the concentration of the homochiral polyepoxy compound represented by formula (II) in the cyclization reaction solution may be 0.01-2.0 mol/L, preferably 0.01-1.0 mol/L, more preferably 0.05 -0.5mol/L, most preferably 0.1-0.3mol/L.
  • the cyclization reaction can be carried out at 0-100°C (preferably 10-60°C; more preferably 20-45°C; most preferably 40°C).
  • the cyclization reaction time may be 0.5-24 hours, preferably 1-18 hours, more preferably 5-18 hours, particularly preferably 12-18 hours, and most preferably 15 hours.
  • halogen means fluorine, chlorine, bromine or iodine.
  • Alkyl represents a straight or branched chain saturated hydrocarbon group containing 1-10 carbon atoms; preferably a straight or branched chain saturated hydrocarbon group containing 1-8 carbon atoms; more preferably a straight chain or branched chain containing 1 to 6 carbon atoms Chain saturated hydrocarbon groups; most preferably straight or branched chain saturated hydrocarbon groups having 1 to 4 carbon atoms.
  • alkyl groups include methyl, ethyl, propyl (including n-propyl, isopropyl), butyl (including n-butyl, isobutyl, tert-butyl), pentyl (including n-pentyl, isopropyl), Pentyl, tert-pentyl, neopentyl) or hexyl, etc.
  • Alkyl alcohol means a compound in which one or more H atoms in the above-mentioned alkyl group is substituted by OH.
  • alkyl alcohols include methanol, ethanol, propanol (including n-propanol, isopropanol), butanol (including n-butanol, isobutanol, tert-butanol), pentanol (including n-pentanol, isoamyl alcohol) Alcohol, tert-amyl alcohol, neopentyl alcohol) or hexanol, etc.
  • Halohydrin refers to a compound in which one or more H atoms in the above-mentioned alkyl alcohol is substituted by halogen; wherein polyhalo refers to 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 15 or more halogens are substituted. Polyhalogenation also means that all H on the alkyl group in the alkyl alcohol is substituted by halogen.
  • halogenated alcohols include trifluoromethanol, trifluoroethanol, perfluoroethanol, trifluoropropanol (including n-propanol, isopropanol), hexafluoropropanol (including n-propanol, isopropanol), perfluoropropanol Propanol (including n-propanol, isopropanol), trifluorobutanol (including n-butanol, isobutanol, tert-butanol), hexafluorobutanol (including n-butanol, isobutanol, tert-butanol) , Perfluorobutanol (including n-butanol, isobutanol, tert-butanol), trifluoropentanol (including n-pentanol, isoamyl alcohol, tert-amyl alcohol, neopen
  • weakly coordinating anions refer to a type of anion that has a very weak interaction force with the cation.
  • the reagents and raw materials used in the present invention are all commercially available.
  • the preparation method of the invention has one or more advantages such as easy preparation of raw materials, short synthetic route, simple experimental operation, mild reaction conditions, rapid reaction and high yield.
  • the preparation method of the present invention can obtain a polyether with 2 trans-fused cyclic ethers at a yield of up to 55%, and obtain a polyether with 3 trans-fused cyclic ethers at a yield of up to 57%, A polyether with 4 trans-fused cyclic ethers was obtained at a yield of up to 40%, and a polyether with an eight-membered ring and 4 trans-fused cyclic ethers was obtained at a yield of up to 19%.
  • the yield is as high as 17% to obtain the polyether with the trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule, and all the above-mentioned synthesis reactions only have one step.
  • the present invention provides a simpler synthetic route for the industrial synthesis of polyethers with trans-fused polycyclic ether skeletons, which has significant social and economic effects, and can be industrialized. The potential is high.
  • FIG. 1 is a hydrogen nuclear magnetic resonance spectrum of a polyether with two trans-fused cyclic ethers obtained in Example 1.
  • FIG. 1 is a hydrogen nuclear magnetic resonance spectrum of a polyether with two trans-fused cyclic ethers obtained in Example 1.
  • FIG. 2 is a carbon nuclear magnetic resonance spectrum of the polyether with two trans-fused cyclic ethers obtained in Example 1.
  • FIG. 3 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 2.
  • FIG. 4 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 2.
  • FIG. 4 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 2.
  • FIG. 5 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3.
  • FIG. 5 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3.
  • FIG. 6 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3.
  • FIG. 6 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3.
  • FIG. 7 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3.
  • FIG. 7 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3.
  • FIG. 8 is a hydrogen nuclear magnetic resonance spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4.
  • FIG. 8 is a hydrogen nuclear magnetic resonance spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4.
  • FIG. 9 is a carbon nuclear magnetic resonance spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4.
  • FIG. 9 is a carbon nuclear magnetic resonance spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4.
  • FIG. 10 is a high-resolution mass spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4.
  • FIG. 10 is a high-resolution mass spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4.
  • FIG. 11 is a hydrogen nuclear magnetic resonance spectrum of the polyether having a trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule obtained in Example 5.
  • FIG. 11 is a hydrogen nuclear magnetic resonance spectrum of the polyether having a trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule obtained in Example 5.
  • Fig. 12 is a carbon nuclear magnetic resonance spectrum of the polyether having a trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule obtained in Example 5.
  • Example 13 is a high-resolution mass spectrum of the polyether having a trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule obtained in Example 5.
  • FIG. 14 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6.
  • FIG. 14 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6.
  • FIG. 15 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6.
  • FIG. 15 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6.
  • FIG. 16 is a high-resolution mass spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6.
  • FIG. 16 is a high-resolution mass spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6.
  • FIG. 17 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 7.
  • FIG. 17 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 7.
  • FIG. 18 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 7.
  • FIG. 18 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 7.
  • FIG. 20 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8.
  • FIG. 20 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8.
  • FIG. 21 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8.
  • FIG. 21 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8.
  • FIG. 22 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8.
  • FIG. 22 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8.
  • FIG. 23 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9.
  • FIG. 23 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9.
  • FIG. 24 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9.
  • FIG. 24 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9.
  • Example 25 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9.
  • the epoxidized compounds used in the examples of this application are all prepared from the corresponding olefinic compounds through the Shi asymmetric epoxidation reaction known in the art (for details, please refer to the document Angew.Chem.Int.Ed.2020, 59, pp 18473 -18478.; Org. Lett. 2012, 14, pp 3932-3935; Science 2007, 317, pp 1189-1192; J. Am. Chem. Soc. 2005, 127, pp 4586-4587), in which Shi asymmetric ring
  • the oxidation reaction conditions are all conventional reaction conditions in the art.
  • the diastereomer mixture of diepoxy alcohol obtained by Shi asymmetric epoxidation (48.4 mg, 0.2 mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of all diepoxy alcohols (R, R) is 89%, That is, 0.178mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C for 15 hours . After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined.
  • the diastereomer mixture of triepoxy alcohol obtained by Shi asymmetric epoxidation (59.6mg, 0.2mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of the substrate of triepoxy alcohol which is all (R, R) is 83%, ie 0.166mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and stirred at 40°C React for 15 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the diastereomeric mixture of tetraepoxy alcohol containing cis-disubstituted olefins obtained by Shi asymmetric epoxidation (78.9 mg, 0.2 mmol, according to the analysis of hydrogen nuclear magnetic spectrum, all of which are (R, R) tetraepoxy
  • the content of the alcohol substrate is 75%, that is, 0.15mmol) is dissolved in perfluoro-tert-butanol (2mL), and then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) is added to it , The reaction was stirred at 40°C for 15 hours. After the reaction was completed, water (5mL) was added to quench the reaction.
  • the reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the organic phases from the three extractions were combined.
  • the organic phase was washed once with water (10mL) and then with brine (10mL) once.
  • the 4-ring trans-fused polycyclic ether of eight-membered cyclic ether After 1 H NMR, 13 C NMR and mass spectrometry analysis, the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 8, the carbon nuclear magnetic resonance spectrum is shown in FIG. 9, and the high-resolution mass spectrum spectrum is shown in FIG. 10.
  • the diastereomer mixture of pentaepoxy alcohol obtained by Shi asymmetric epoxidation (90.5mg, 0.2mmol, according to the proton nuclear magnetic spectrum analysis, the content of all (R, R) pentaepoxy alcohol substrate is 71 %, that is, 0.142mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C. 15 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the diastereomeric mixture of triepoxy alcohol obtained by Shi asymmetric epoxidation (54.0 mg, 0.2 mmol, and the content of the substrate of triepoxy alcohol which is all (R, R) according to the proton nuclear magnetic spectrum analysis is 83%, ie 0.166mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and stirred at 40°C React for 24 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the diastereomer mixture of triepoxy alcohol obtained by Shi asymmetric epoxidation (51.2 mg, 0.2 mmol, according to the proton nuclear magnetic spectrum analysis, the content of the substrate of triepoxy alcohol which is all (R, R) is 83%, ie 0.166mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and stirred at 40°C React for 24 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the diastereomer mixture of THP-protected hydroxyl triepoxy obtained by Shi asymmetric epoxidation (68.0mg, 0.2mmol, according to the proton nuclear magnetic spectrum analysis, all of which are (R, R) triepoxy substrates
  • the content is 83%, that is, 0.166mmol
  • perfluoro-tert-butanol (2mL) perfluoro-tert-butanol
  • 1-ethyl-3-methylimidazole tetrafluoroborate 40mg, 0.2mmol
  • the product was analyzed by 1 H NMR, 13 C NMR and mass spectrometry.
  • the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 17, the carbon nuclear magnetic resonance spectrum is shown in FIG. 18, and the high-resolution mass spectrum spectrum is shown in FIG. 19.
  • the diastereomer mixture of tetraepoxy alcohol obtained by Shi asymmetric epoxidation (70.8 mg, 0.2 mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of which is all (R, R) tetraepoxy alcohol substrate is 75 %, ie 0.15mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C 24 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the diastereomer mixture of tetraepoxy alcohol obtained by Shi asymmetric epoxidation (68.0mg, 0.2mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of all tetraepoxy alcohol substrates of (R, R) is 75 %, ie 0.15mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C 20 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the diastereomer mixture of THP-protected hydroxyl tetraepoxy obtained by Shi asymmetric epoxidation (84.9mg, 0.2mmol, according to the hydrogen nuclear magnetic spectrum analysis of the content of all (R, R) tetraepoxy substrates 75%, ie 0.15mmol) was dissolved in perfluoro-tert-butanol (2mL), and then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, at 40°C The reaction was stirred for 20 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time.
  • the product was analyzed by 1 H NMR, 13 C NMR and mass spectrometry, and the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 23, the carbon nuclear magnetic resonance spectrum is shown in FIG. 24, and the high-resolution mass spectrum spectrum is shown in FIG. 25.
  • the synthesis method of the present invention can obtain a polyether with 2 trans-fused cyclic ethers at a yield of up to 55%, and obtain a polyether with 3 trans-fused cyclic ethers at a yield of up to 57%.
  • the polyether of the cyclic ether is obtained with a yield of up to 40%, and the polyether with 4 trans-fused cyclic ethers is obtained with a yield of up to 19%. It contains an eight-membered ring and has 4 trans-fused
  • the polyether of the cyclic ether is as high as 17% to obtain the polyether with the trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule.
  • the method for synthesizing a polyether with a trans-fused polycyclic ether skeleton structure from a long-chain homochiral polyepoxy compound through a one-step tandem reaction provided by the present invention has raw materials that can be conveniently prepared from cheap and readily available reagents.
  • the experimental operation is simple, the reaction conditions are mild, and the reaction is fast.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epoxy Compounds (AREA)

Abstract

The present invention provides a method for one-step preparation of polyether having a trans-fused polycyclic ether framework structure. In particular, the present invention provides a preparation method for a trans-fused polycyclic ether compound represented by formula (I), comprising the following steps: in the presence of a reaction medium and a salt containing a weakly coordinating anion, preparing a trans-fused polycyclic ether compound represented by formula (I) by subjecting a homochiral polyepoxy compound represented by formula (II) to a one-step cyclization reaction. The preparation method of the present invention has one or more advantages such as easy preparation of raw materials, short synthetic route, simple experimental operation, mild reaction conditions, rapid reaction and high yield.

Description

一步法制备具有反式稠合多聚环醚骨架结构的聚醚的方法One-step method for preparing polyether with trans-fused polycyclic ether skeleton structure
相关申请的交叉引用Cross-references to related applications
本申请要求申请日为2020/06/12的中国专利申请202010532858.8的优先权。本申请引用上述中国专利申请的全文。This application claims the priority of the Chinese patent application 202010532858.8 whose filing date is 2020/06/12. This application quotes the full text of the aforementioned Chinese patent application.
技术领域Technical field
本发明涉及一种一步法制备具有反式稠合多聚环醚骨架结构的聚醚的方法。The invention relates to a one-step method for preparing a polyether with a trans-fused polycyclic ether skeleton structure.
背景技术Background technique
1981年第一个海洋聚醚毒素短裸甲藻毒素B(brevetoxinB)的结构被确定为具有11个反式稠合的环醚的多聚环醚类化合物(J.Am.Chem.Soc.1981,103,pp 6773-6775),在这之后的若干年中,科学家又陆续从海洋藻类中发现了50多个海洋聚醚毒素。对这些海洋聚醚毒素的结构鉴定表明这些化合物分子内都具有相类似的反式稠合的多聚环醚骨架结构,即分子中含有多个以trans-syn-trans相对立体构型稠合而成的环醚(环醚的大小为五元环醚、六元环醚、七元环醚、八元环醚、九元环醚),由于含有多个稠合的环醚,海洋聚醚毒素的分子骨架呈梯子形状,故又名梯形稠聚醚毒素。下图列出的是典型的海洋聚醚毒素短裸甲藻毒素B(brevetoxin B)、hemibrevetoxin B、brevenal、短裸甲藻毒素A(brevetoxin A)、雪卡毒素3C(ciguatoxin 3C)的化学结构式(Chem.Rev.1993,93,pp1897-1909)。In 1981, the structure of the first marine polyether toxin brevetoxin B (brevetoxinB) was determined to be a polycyclic ether compound with 11 trans-fused cyclic ethers (J.Am.Chem.Soc.1981) , 103, pp 6773-6775). In the following years, scientists have discovered more than 50 marine polyether toxins from marine algae. The structural identification of these marine polyether toxins showed that these compounds all have similar trans-fused polycyclic ether skeleton structures in their molecules, that is, the molecules contain multiple trans-syn-trans relative three-dimensional configurations. The cyclic ether (the size of the cyclic ether is five-membered cyclic ether, six-membered cyclic ether, seven-membered cyclic ether, eight-membered cyclic ether, and nine-membered cyclic ether). Because it contains multiple fused cyclic ethers, marine polyether toxins The molecular skeleton of the product is in the shape of a ladder, so it is also known as a trapezoidal thick polyether toxin. The following figure lists the chemical structural formulas of typical marine polyether toxin brevetoxin B (brevetoxin B), hemibrevetoxin B, brevenal, brevetoxin A (brevetoxin A), and ciguatoxin 3C (ciguatoxin 3C) (Chem. Rev. 1993, 93, pp1897-1909).
Figure PCTCN2021099762-appb-000001
Figure PCTCN2021099762-appb-000001
海洋藻类产生的海洋聚醚毒素一般都具有极强的神经毒性,当海洋藻类病态地大量繁殖时,其所产生的海洋聚醚毒素可导致海洋生物大量死亡。海洋聚醚毒素也可通过食物链的传递富集在鱼虾或贝类体内,若被污染的鱼虾或贝类被人类不慎食用就会引起中毒反应,严重时可导致死亡(Toxicon 2001,39,pp 97-106)。但是也有一些海洋聚醚具有可以开发为药物的生物活性(Chem.Res.Toxicol.2004,17,pp 1251-1257),研究表明由海洋藻类腰鞭毛藻(karenia brevis)产生的海洋聚醚brevenal本身没有神经毒性,但具有改善囊肿性纤维化病(cystic fibrosis)的生物活性(Science 2007,316,pp 1561-1562),囊肿性纤维化病是一种遗传性的肺部疾病,患者的肺部会反复受到细菌感染,全世界有7万多名患有囊肿性纤维化病的患者,目前尚未找到有效的治疗方法。2018年,brevenal被美国FDA批准作为孤儿药进入治疗囊肿性纤维化病的一期临床实验。近期对brevenal的 研究表明,brevenal对其他慢性肺部疾病也有潜在的治疗作用(Mar.Drugs 2019,17,pp 184)。对brevenal的研究还表明brevenal还可以竞争性地结合短裸甲藻毒素和雪卡毒素在人体内的蛋白受体,从而可以减轻短裸甲藻毒素和雪卡毒素造成的中毒反应(Cell.Mol.Neurobiol.2004,24,pp 553-563)。Marine polyether toxins produced by marine algae generally have strong neurotoxicity. When marine algae multiply morbidly, the marine polyether toxins produced by them can cause a large number of deaths of marine organisms. Marine polyether toxins can also be concentrated in fish, shrimp or shellfish through the transmission of the food chain. If the contaminated fish, shrimp or shellfish is accidentally eaten by humans, it will cause a poisoning reaction, which can lead to death in severe cases (Toxicon 2001, 39). , Pp 97-106). But there are also some marine polyethers that have biological activity that can be developed as drugs (Chem. Res. Toxicol. 2004, 17, pp 1251-1257). Studies have shown that the marine polyether brevenal itself produced by the marine algae Karenia brevis It has no neurotoxicity, but has the biological activity of improving cystic fibrosis (Science 2007, 316, pp 1561-1562). Cystic fibrosis is a hereditary lung disease. The patient’s lungs Will be repeatedly infected by bacteria. There are more than 70,000 patients with cystic fibrosis in the world, and no effective treatment has yet been found. In 2018, brevenal was approved by the US FDA as an orphan drug to enter a phase I clinical trial for the treatment of cystic fibrosis. Recent studies on brevenal have shown that brevenal also has a potential therapeutic effect on other chronic lung diseases (Mar. Drugs 2019, 17, pp 184). Studies on brevenal also show that brevenal can also competitively bind to the protein receptors of breven pyridine toxin and ciguatoxin in the human body, thereby reducing the poisoning reaction caused by breven pyridine toxin and ciguatoxin (Cell.Mol .Neurobiol. 2004, 24, pp 553-563).
虽然brevenal是囊肿性纤维化病等慢性肺部疾病的潜在治疗选择,但是病人每天使用brevenal或其衍生的药物将会非常昂贵。腰鞭毛藻产生的brevenal含量非常低,仅靠提取难以大量获得brevenal。含有反式稠合的7/7/6/7/6五环醚结构的brevenal也可以通过人工合成的方法获得,目前已经报道的brevenal的全合成路线一共有6条,2006年日本东北大学Sasaki教授课题组首次报道了brevenal的全合成,他们以2-脱氧-D-核糖为起始原料,使用Suzuki-Miyaura交叉偶联反应对brevenal的AB环片段和DE环片段进行拼接后再构建C环,后续通过一系列转化引入侧链,该路线总步数超过50步(下图a,J.Am.Chem.Soc.2006,128,pp 16989-16999);2008年他们报道的第二代合成路线需要47步,总收率为0.2%(Org.Lett.2008,10,pp 2275-2278);2011年,该小组再次报道了一条更为高效的第三代的总步数为40步的合成路线,总收率为2.26%(Chem.Eur.J.2011,17,pp 13754-13761);2009年日本冈山大学的Kadota教授课题组也报道了brevenal的全合成,他们的第一代全合成路线通过α-氯乙酰氧基醚的分子内烯丙基化反应和紧随其后的关环复分解构建起brevenal的DE环,总共57步全合成的总收率为0.84%(下图b,Org.Lett.2009,11,pp 2531-2534);2010年Kadota教授课题组的第二代全合成路线需要53步,总收率为1.8%(Tetrahedron 2010,66,pp 5329-5344);2011年美国犹他大学的Rainier教授课题组利用关键的烯酯环化反应等实现了brevenal的CD两环的构建,他们的brevenal全合成路线为38步,总收率为0.99%(下图c,J.Am.Chem.Soc.2011,133,pp 3208-3216)。纵观brevenal的这6条全合成路线可以发现,如果通过逐碳逐环地构建brevenal分子中的反式稠合的7/7/6/7/6五环醚骨架结构,需要十分冗长的合成路线和昂贵的合成试剂。Although brevenal is a potential treatment option for chronic lung diseases such as cystic fibrosis, the daily use of brevenal or its derivatives will be very expensive for patients. The content of brevenal produced by Lusoflagellate is very low, and it is difficult to obtain large amounts of brevenal only by extraction. The brevenal containing the trans-fused 7/7/6/7/6 pentacyclic ether structure can also be obtained by artificial synthesis. At present, there are 6 total synthetic routes of brevenal that have been reported. In 2006, Sasaki, Tohoku University, Japan The professor’s group reported the total synthesis of brvenal for the first time. They used 2-deoxy-D-ribose as the starting material and used the Suzuki-Miyaura cross-coupling reaction to splice the AB and DE ring fragments of brvenal before constructing the C ring. , The subsequent introduction of the side chain through a series of transformations, the total number of steps in this route exceeds 50 steps (Figure a below, J.Am.Chem.Soc.2006, 128, pp 16989-16999); they reported the second-generation synthesis in 2008 The route requires 47 steps, with a total yield of 0.2% (Org.Lett.2008, 10, pp 2275-2278); in 2011, the team once again reported a more efficient third-generation with a total of 40 steps Synthetic route, the total yield is 2.26% (Chem.Eur.J.2011, 17, pp 13754-13761); in 2009, Professor Kadota's research group from Okayama University in Japan also reported the total synthesis of brevenal, their first generation The total synthesis route constructs the DE ring of brevenal through the intramolecular allylation reaction of α-chloroacetoxy ether and the subsequent ring-closure metathesis. The total yield of total synthesis of 57 steps is 0.84% (Figure b, Org. Lett. 2009, 11, pp 2531-2534); In 2010, the second-generation total synthesis route of Professor Kadota’s research group required 53 steps, with a total yield of 1.8% (Tetrahedron 2010, 66, pp 5329-5344) ; In 2011, Professor Rainier's research group from the University of Utah used the key enester cyclization reaction to achieve the construction of the two-ring CD of brevenal. Their total synthesis route of brevenal was 38 steps, and the total yield was 0.99% (Figure c below) , J. Am. Chem. Soc. 2011, 133, pp 3208-3216). Looking at the six total synthesis routes of brevenal, it can be found that if the trans-fused 7/7/6/7/6 pentacyclic ether skeleton structure in the brevenal molecule is constructed carbon by carbon and ring by ring, a very lengthy synthesis is required. Routes and expensive synthetic reagents.
Figure PCTCN2021099762-appb-000002
Figure PCTCN2021099762-appb-000002
上世纪80年代日本的化学家Nakanishi注意到每个海洋聚醚毒素分子中都含有虽然环数和环大小不一,但是很规律性的反式稠合的多聚环醚骨架,Nakanishi对brevetoxin B的生源途径提出了著名的Nakanishi猜想(下图,Toxicon 1985,23,pp 473-479)。该猜想推测一个(R,R)选择性的环氧化酶催化长链的多烯前体的不对称环氧化反应,给出长链的手性全部为(R,R)的多环氧化合物,接着该同手性多环氧化合物发生一步分子内的endo,endo-选择性串联环氧开环环化反应,一步反应构建brevetoxin B中反式稠合的11个环醚。如果能以Nakanishi猜想的方式,通过分子内串联反应快速地构筑反式稠合的多聚环醚的骨架结构,就可以大大简化海洋聚醚药物brevenal的合成。In the 1980s, Japanese chemist Nakanishi noticed that every marine polyether toxin molecule contains a regular trans-fused polycyclic ether skeleton, although the number and size of the ring are different. The birth path of the student puts forward the famous Nakanishi conjecture (the figure below, Toxicon 1985, 23, pp 473-479). This conjecture speculates that a (R, R) selective cyclooxygenase catalyzes the asymmetric epoxidation reaction of long-chain polyene precursors, giving a long-chain polyepoxy with all (R, R) chirality The compound, and then the homochiral polyepoxy compound undergoes a one-step intramolecular endo, endo-selective series epoxy ring-opening and cyclization reaction, and a one-step reaction constructs 11 trans-fused cyclic ethers in brevetoxin B. If the backbone structure of the trans-fused polycyclic ether can be quickly constructed through the intra-molecular tandem reaction in the way Nakanishi conjectured, the synthesis of the marine polyether drug brevenal can be greatly simplified.
Figure PCTCN2021099762-appb-000003
Figure PCTCN2021099762-appb-000003
Nakanishi猜想中的串联反应的前体化合物,长链的多环氧化合物可以由长链的多烯化合物通过Shi不对称环氧化一步合成,长链的多烯化合物可以由商业可得的小分子原料通过Wittig反应、过渡金属催化的偶联反应等有机反应制备,所以以串联反应的前体化合物在有机合成上是容易制备的,但是由长链的同手性多环氧前体的一步串联环氧开环环化反应,来构建一个具有反式稠合多聚环醚骨架的海洋聚醚毒素,即Nakanishi猜想,至今仍然没有实现。这是因为根据Baldwin分子内环化反应经验规则,由分子内的单环氧开环环化反应生成单个的环醚时,倾向于以exo方式生成较小的五元环醚,以endo方式环化生成六元环醚在能量上是不利的(下图a,J.Chem.Soc.Chem.Commun.1976,pp734-736)。而Nakanishi猜想中所提出的关键串联环化是通过分子内endo,endo-串联环氧开环环化方式进行的,根据Baldwin规则endo,endo-选择性串联环氧开环环化相对exo,exo-串联环氧开环环化在能量上是不利的,而只有多环氧化合物的endo,endo-选择性串联环氧开环环化能生成反式稠合的多聚环醚结构,exo,exo-串联环氧开环环化生成的是非稠合的,由碳碳单键连接的多聚环醚结构(下图b)。The precursor compound of the tandem reaction in Nakanishi's conjecture, long-chain polyepoxy compounds can be synthesized from long-chain polyene compounds by Shi asymmetric epoxidation in one step, and long-chain polyene compounds can be synthesized from commercially available small molecules. The raw materials are prepared by organic reactions such as Wittig reaction and transition metal-catalyzed coupling reaction, so the precursor compound of the tandem reaction is easy to prepare in organic synthesis, but it is a one-step series connection of long-chain homochiral polyepoxy precursors. The epoxy ring-opening and cyclization reaction to construct a marine polyether toxin with a trans-fused polycyclic ether skeleton, the Nakanishi conjecture, has still not been realized. This is because according to the empirical rules of Baldwin intramolecular cyclization reaction, when a single cyclic ether is generated from the intramolecular monoepoxy ring-opening and cyclization reaction, it tends to form a smaller five-membered cyclic ether in the exo mode, and the ring in the endo mode. The formation of six-membered cyclic ethers is energy unfavorable (Figure a below, J. Chem. Soc. Chem. Commun. 1976, pp734-736). The key tandem cyclization proposed in the Nakanishi conjecture is carried out by intramolecular endo, endo- tandem epoxy ring-opening cyclization. According to the Baldwin rule, endo-selective tandem epoxy ring-opening cyclization is relatively exo, exo -Tandem epoxy ring-opening and cyclization is unfavorable in terms of energy, and only polyepoxy compound endo, endo-selective tandem epoxy ring-opening and cyclization can generate trans-fused polycyclic ether structure, exo, The exo-series epoxy ring-opening cyclization produces a non-condensed polycyclic ether structure connected by a single carbon-carbon bond (Figure b below).
Figure PCTCN2021099762-appb-000004
Figure PCTCN2021099762-appb-000004
目前在这一极富挑战的研究领域中,有3例报道能通过多环氧前体化合物分子内endo,endo-选择性串联环氧开环环化反应构筑反式稠合的多聚环醚结构。2000年,日本的Murai课题组发展了镧盐催化的同手性多环氧前体化合物的分子内endo,endo-选择性串联环氧开环环化反应,通过向三环氧底物的每个环氧的exo环化位点引入甲氧基甲基,能够得到较好的endo选择性,但是含有三个反式稠合的六元环的聚醚产物的收率仅为9%(Synlett 2000,pp 335-338)。At present, in this extremely challenging research field, there are 3 cases reported that the trans-fused polycyclic ether can be constructed through the intramolecular endo, endo-selective series epoxy ring-opening and cyclization reaction of the polyepoxy precursor compound. structure. In 2000, the Murai research group in Japan developed the intramolecular endo, endo-selective tandem epoxy ring-opening and cyclization reaction of homochiral polyepoxy precursor compounds catalyzed by lanthanum salt. The introduction of a methoxymethyl group into the exo cyclization site of an epoxy can achieve better endo selectivity, but the yield of the polyether product containing three trans-fused six-membered rings is only 9% (Synlett 2000, pp 335-338).
Figure PCTCN2021099762-appb-000005
Figure PCTCN2021099762-appb-000005
2002年,美国的McDonald课题组发现当同手性多环氧前体化合物以羰基而不是羟基作为终止基团时,多环氧前体化合物在Lewis酸催化下可以发生分子内endo,endo-选择性串联环氧开环环化反应,实现了反式稠合的全部环醚为七元环的聚醚的构筑,其中含有4个七元环的聚醚的收率仅为12%(J.Org.Chem.2002,67,pp 2515-2523)。In 2002, the McDonald research group in the United States found that when the homochiral polyepoxy precursor compound has a carbonyl group instead of a hydroxyl group as the terminating group, the polyepoxy precursor compound can undergo intramolecular endo, endo-selection under the catalysis of Lewis acid. The serial epoxy ring-opening and cyclization reaction realizes the construction of polyethers in which all the trans-fused cyclic ethers are seven-membered rings. The yield of polyethers containing four seven-membered rings is only 12% (J. Org. Chem. 2002, 67, pp 2515-2523).
Figure PCTCN2021099762-appb-000006
Figure PCTCN2021099762-appb-000006
2007年,Jamison课题组发现在长链同手性多环氧底物的一端事先放置一个四氢吡喃环作为引导结构,在热水中多环氧底物可以发生分子内endo,endo-选择性的串联环氧开环环化反应,生成反式稠合的全部环醚为六元环的聚醚,其中含有4个六元环的聚醚的收率为53%(Science 2007,317,pp 1189-1192)。In 2007, Jamison’s research group discovered that a tetrahydropyran ring was placed in advance at one end of a long-chain homochiral polyepoxy substrate as a guiding structure. In hot water, the polyepoxy substrate can undergo intramolecular endo, endo-selection. The serial epoxy ring-opening and cyclization reaction produces a trans-fused polyether whose all cyclic ethers are six-membered rings. The yield of polyethers containing four six-membered rings is 53% (Science 2007, 317, pp 1189-1192).
Figure PCTCN2021099762-appb-000007
Figure PCTCN2021099762-appb-000007
这3例报道中前两例收率偏低,而且这3例报道只能生成全部是六元环的聚醚或全部是七元环的聚醚,而具有生物活性的海洋聚醚毒素brevenal分子中具有混合有六元环醚和七元环醚的7/7/6/7/6五环结构。另外,许多具有生物活性的海洋聚醚毒素中都含有八元环醚或九元环醚,用现有的endo,endo-选择性的串联环氧开环环化方法无法合成分子中含有八元环醚或九元环醚的聚醚。The yields of the first two cases of these 3 cases are low, and these 3 cases can only produce all six-membered ring polyethers or all seven-membered ring polyethers, while the biologically active marine polyether toxin brevenal molecule It has a 7/7/6/7/6 five-ring structure mixed with six-membered cyclic ether and seven-membered cyclic ether. In addition, many biologically active marine polyether toxins contain eight-membered cyclic ethers or nine-membered cyclic ethers. The existing endo, endo-selective tandem epoxy ring-opening and cyclization method cannot be used to synthesize molecules containing eight-membered cyclic ethers. Cyclic ethers or polyethers of nine-membered cyclic ethers.
发明内容Summary of the invention
本发明所要解决的技术问题是现有技术中反式稠合多聚环醚骨架结构的聚醚的制备方法较为单一,从而提供一种新的一步法制备具有反式稠合多聚环醚骨架结构的聚醚(trans-fused polycyclic polyether)的方法。本方法以易于制备的长链的同手性多环氧化合物为原料,可经一步分子内endo,endo-选择性串联环氧开环环化反应,合成反式稠合多聚环醚化合物,所形成的多聚环醚化合物中的环醚可以为六元环醚、七元环醚、八元环醚、九元环醚或其组合。The technical problem to be solved by the present invention is that the preparation method of polyether with trans-fused polycyclic ether skeleton structure in the prior art is relatively simple, thereby providing a new one-step method for preparing polyether with trans-fused polycyclic ether skeleton Structured polyether (trans-fused polycyclic polyether) method. This method uses easy-to-prepare long-chain homochiral polyepoxy compounds as raw materials, and can synthesize trans-fused polycyclic ether compounds through a one-step intramolecular endo, endo-selective serial epoxy ring-opening and cyclization reaction. The cyclic ether in the formed polycyclic ether compound may be a six-membered cyclic ether, a seven-membered cyclic ether, an eight-membered cyclic ether, a nine-membered cyclic ether, or a combination thereof.
本发明提供了一种式(I)所示的反式稠合多聚环醚化合物的制备方法,其包括如下步骤:在反应介质和含弱配位阴离子的盐的存在下,式(II)所示的同手性多环氧化合物经一步环化反应制备得到式(I)所示的反式稠合多聚环醚化合物;The present invention provides a method for preparing a trans-fused polycyclic ether compound represented by formula (I), which comprises the following steps: in the presence of a reaction medium and a salt containing a weak coordination anion, the formula (II) The homochiral polyepoxy compound shown is prepared by a one-step cyclization reaction to obtain the trans-fused polycyclic ether compound represented by formula (I);
Figure PCTCN2021099762-appb-000008
Figure PCTCN2021099762-appb-000008
(下标u、v、x和y用于标示片段结构,*、#和&用于标记碳原子,无其他含义)(The subscripts u, v, x and y are used to indicate the structure of the fragment, *, # and & are used to indicate the carbon atom and have no other meaning)
其中,在式(I)所示的反式稠合多聚环醚化合物以及式(II)所示的同手性多环氧化合物中:Among them, in the trans-fused polycyclic ether compound represented by formula (I) and the homochiral polyepoxy compound represented by formula (II):
各个R相同或不同,其独立选自H、C 1-3烷基-或卤代C 1-3烷基-;特别优选H、甲基、乙基、丙基或异丙基;最优选H或甲基; Each R is the same or different, and is independently selected from H, C 1-3 alkyl- or halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl or isopropyl; most preferably H Or methyl
各个R 1相同或不同,其独立选自H、C 1-10烷基-、C 1-10烷基-O-C 1-10烷基-、C 6-10芳基-C 1-10烷基-O-C 1-10烷基-、卤代C 1-10烷基-;优选H、C 1-6烷基-、C 1-6烷基-O-C 1-6烷基-、C 6-10芳基-C 1-6烷基-O-C 1-6烷基-、卤代C 1-6烷基-;更优选H、C 1-3烷基-、C 1-3烷基-O-C 1-3烷基-、苯基-C 1-3烷基-O-C 1-3烷基-、卤代C 1-3烷基-;特别优选H、甲基、乙基、丙基、异丙基;最优选H、甲基; Each R 1 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H. Methyl;
各个R 2相同或不同,其独立选自H、C 1-10烷基-、C 1-10烷基-O-C 1-10烷基-、C 6-10芳基-C 1-10烷基-O-C 1-10烷基-、卤代C 1-10烷基-;优选H、C 1-6烷基-、C 1-6烷基-O-C 1-6烷基-、C 6-10芳基-C 1-6烷基-O-C 1-6烷基-、卤代C 1-6烷基-;更优选H、C 1-3烷基-、C 1-3烷基-O-C 1-3烷基-、苯基-C 1-3烷基-O-C 1-3烷基-、卤代C 1-3烷基-;特别优选H、甲基、乙基、丙基、异丙基;最优选H、甲基;或者,R 2在与双键碳原子相连的情况下,则R 2不存在; Each R 2 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H, methyl; or, when R 2 is connected to a double-bonded carbon atom, R 2 does not exist;
各个n相同或不同,其独立选自1、2、3、4;Each n is the same or different, and is independently selected from 1, 2, 3, 4;
Figure PCTCN2021099762-appb-000009
片段中碳原子可以任选被以下基团取代:H、OH、C 1-4烷基-或卤代C 1-4烷基-;
Figure PCTCN2021099762-appb-000009
The carbon atoms in the fragments can be optionally substituted by the following groups: H, OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-;
当n=2或3或4时,在适合的情况下,式(I)的聚醚化合物和式(II)的多环氧化合物中相邻两个碳原子之间任选形成C=C双键,且式(II)的多环氧化合物中的C=C双键位置与作为产物的式(I)的聚醚化合物中的C=C双键位置相对应;When n=2 or 3 or 4, where appropriate, the polyether compound of formula (I) and the polyepoxy compound of formula (II) optionally form a C=C double between adjacent two carbon atoms The position of the C=C double bond in the polyepoxy compound of formula (II) corresponds to the position of the C=C double bond in the polyether compound of formula (I) as the product;
R 3为H或对酸敏感的羟基保护基;所述对酸敏感的羟基保护基例如醚类保护基(例如THP(2-四氢吡喃基))、硅醚保护基(例如TMS(三甲基硅基)或TES(三乙基硅基)),优选为THP、TMS,最优选THP; R 3 is H or an acid-sensitive hydroxyl protecting group; the acid-sensitive hydroxyl protecting group is for example an ether protecting group (such as THP (2-tetrahydropyranyl)), a silyl ether protecting group (such as TMS (three Methylsilyl) or TES (triethylsilyl)), preferably THP, TMS, most preferably THP;
在式(I)所示的反式稠合多聚环醚化合物中,
Figure PCTCN2021099762-appb-000010
部分表示x片段和y片段依次交替重复出现的结构,整个式(I)结构中x片段数目Nx≥1,Nx具体可以为1、2、3、4、5、6、7、8、9、10、11;y片段数目Ny≥0,Ny具体可以为0、1、2、3、4、5、6、7、8、9、10;且1≤Nx+Ny≤20,优选1≤Nx+Ny≤15,更优选1≤Nx+Ny≤10,特别优选1≤Nx+Ny≤8(例如Nx+Ny=1、2、3、4、5、6、7或8),最优选1≤Nx+Ny≤4(例如Nx+Ny=1、2、3或4);
In the trans-fused polycyclic ether compound represented by formula (I),
Figure PCTCN2021099762-appb-000010
The part represents the structure in which the x fragments and the y fragments appear alternately and repeatedly. The number of x fragments in the structure of formula (I) is Nx≥1, and Nx can specifically be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11; the number of y fragments Ny≥0, Ny can specifically be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10; and 1≤Nx+Ny≤20, preferably 1≤Nx +Ny≤15, more preferably 1≤Nx+Ny≤10, particularly preferably 1≤Nx+Ny≤8 (for example, Nx+Ny=1, 2, 3, 4, 5, 6, 7 or 8), most preferably 1 ≤Nx+Ny≤4 (for example, Nx+Ny=1, 2, 3 or 4);
在式(II)所示的同手性多环氧化合物中,
Figure PCTCN2021099762-appb-000011
部分表示u片段和v片段依次交替重复出现的结构,整个式(II)结构中u片段数目Nu≥1,Nu具体可以为1、2、3、4、5、6、7、8、9、10、11;v片段数目Nv≥0,Nv具体可以为0、1、2、3、4、5、6、7、8、9、10;且1≤Nu+Nv≤20,优选1≤Nu+Nv≤15,更优选1≤Nu+Nv≤10,特别优选1≤Nu+Nv≤8(例如Nu+Nv=1、2、3、4、5、6、7或8),最优选1≤Nu+Nv≤4(例如Nu+Nv=1、2、3或4);
In the homochiral polyepoxy compound represented by formula (II),
Figure PCTCN2021099762-appb-000011
The part represents the structure in which u fragments and v fragments appear alternately and repeatedly, the number of u fragments in the entire structure of formula (II) is Nu≥1, and Nu can specifically be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11; the number of v fragments Nv≥0, Nv can specifically be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10; and 1≤Nu+Nv≤20, preferably 1≤Nu +Nv≤15, more preferably 1≤Nu+Nv≤10, particularly preferably 1≤Nu+Nv≤8 (for example, Nu+Nv=1, 2, 3, 4, 5, 6, 7 or 8), most preferably 1 ≤Nu+Nv≤4 (for example, Nu+Nv=1, 2, 3 or 4);
在同一反应中,Nx+Ny=Nu+Nv。In the same reaction, Nx+Ny=Nu+Nv.
为了便于理解本发明,进一步对
Figure PCTCN2021099762-appb-000012
片段说明如下:在式(I)所示的反式稠合多聚环醚化合物中,Nx+Ny=1时,则y片段以及
Figure PCTCN2021099762-appb-000013
部分为不存在;Nx+Ny=2 时,则
Figure PCTCN2021099762-appb-000014
部分为不存在;Nx+Ny=3时,则
Figure PCTCN2021099762-appb-000015
部分为x片段;Nx+Ny=4时,则
Figure PCTCN2021099762-appb-000016
部分为x-y片段;Nx+Ny=5时,则
Figure PCTCN2021099762-appb-000017
部分为x-y-x片段;Nx+Ny=6时,则
Figure PCTCN2021099762-appb-000018
部分为x-y-x-y片段;依次类推。
In order to facilitate the understanding of the present invention, further
Figure PCTCN2021099762-appb-000012
The fragment description is as follows: In the trans-fused polycyclic ether compound represented by formula (I), when Nx+Ny=1, then the y fragment and
Figure PCTCN2021099762-appb-000013
Part is not present; when Nx+Ny=2, then
Figure PCTCN2021099762-appb-000014
Part is not present; when Nx+Ny=3, then
Figure PCTCN2021099762-appb-000015
Part is x fragment; when Nx+Ny=4, then
Figure PCTCN2021099762-appb-000016
Part of it is an xy segment; when Nx+Ny=5, then
Figure PCTCN2021099762-appb-000017
Part is xyx fragment; when Nx+Ny=6, then
Figure PCTCN2021099762-appb-000018
Part is xyxy fragment; and so on.
为了便于理解本发明,进一步对
Figure PCTCN2021099762-appb-000019
片段说明如下:在式(II)的同手性多环氧化合物中,Nu+Nv=1时,则v片段以及
Figure PCTCN2021099762-appb-000020
部分为不存在;Nu+Nv=2时,则
Figure PCTCN2021099762-appb-000021
部分为不存在;Nu+Nv=3时,则
Figure PCTCN2021099762-appb-000022
部分为u片段;即Nu+Nv=4时,则
Figure PCTCN2021099762-appb-000023
部分为u-v片段;Nu+Nv=5时,则
Figure PCTCN2021099762-appb-000024
部分为u-v-u片段;Nu+Nv=6时,则
Figure PCTCN2021099762-appb-000025
部分为u-v-u-v片段;依次类推。
In order to facilitate the understanding of the present invention, further
Figure PCTCN2021099762-appb-000019
The fragment description is as follows: in the homochiral polyepoxy compound of formula (II), when Nu+Nv=1, then the v fragment and
Figure PCTCN2021099762-appb-000020
Part is not present; when Nu+Nv=2, then
Figure PCTCN2021099762-appb-000021
Part is not present; when Nu+Nv=3, then
Figure PCTCN2021099762-appb-000022
Part is u fragment; that is, when Nu+Nv=4, then
Figure PCTCN2021099762-appb-000023
Part is uv fragment; when Nu+Nv=5, then
Figure PCTCN2021099762-appb-000024
Part is uvu fragment; when Nu+Nv=6, then
Figure PCTCN2021099762-appb-000025
Some are uvuv fragments; and so on.
本领域技术人员可以理解的是,式(I)和式(II)结构中,u片段数目Nu=x片段数目Nx,v片段数目Nv=y片段数目Ny。Those skilled in the art can understand that in the structures of formula (I) and formula (II), the number of u fragments Nu=the number of x fragments Nx, and the number of v fragments Nv=the number of y fragments Ny.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和同手性多环氧化合物的结构定义如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the homochiral polyepoxy compound are defined as follows:
Figure PCTCN2021099762-appb-000026
Figure PCTCN2021099762-appb-000026
其中,在式(I)的聚醚化合物以及式(II)的多环氧化合物中,各个R相同或不同,其独立选自H、C 1-3烷基-、卤代C 1-3烷基-;特别优选H、甲基、乙基、丙基、异丙基;最优选H、甲基。 Wherein, in the polyether compound of formula (I) and the polyepoxy compound of formula (II), each R is the same or different, and is independently selected from H, C 1-3 alkyl-, halogenated C 1-3 alkane Group -; H, methyl, ethyl, propyl, isopropyl are particularly preferred; H, methyl is most preferred.
各个R 1相同或不同,其独立选自H、C 1-10烷基-、C 1-10烷基-O-C 1-10烷基-、C 6-10芳基-C 1-10烷基-O-C 1-10烷基-、卤代C 1-10烷基-;优选H、C 1-6烷基-、C 1-6烷基-O-C 1-6烷基-、C 6-10芳基-C 1-6烷基-O-C 1-6烷基-、卤代C 1-6烷基-;更优选H、C 1-3烷基-、C 1-3烷基-O-C 1-3烷基-、苯基-C 1-3烷基-O-C 1-3烷基-、卤代C 1-3烷基-;特别优选H、甲基、乙基、丙基、异丙基;最优选H、甲基; Each R 1 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H. Methyl;
各个R 2相同或不同,其独立选自H、C 1-10烷基-、C 1-10烷基-O-C 1-10烷基-、C 6-10芳基-C 1-10烷基-O-C 1-10烷基-、卤代C 1-10烷基-;优选H、C 1-6烷基-、C 1-6烷基-O-C 1-6烷基-、C 6-10芳基-C 1-6烷基-O-C 1-6烷基-、卤代C 1-6烷基-;更优选H、C 1-3烷基-、C 1-3烷基-O-C 1-3烷基-、苯基-C 1-3烷基-O-C 1-3烷基-、卤代C 1-3烷基-;特别优选H、甲基、乙基、丙基、异丙基;最优选H、甲基;或者,R 2在与双键碳原子相连的情况下,则R 2不存在; Each R 2 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-; preferably H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, C 6-10 aryl -C 1-6 alkyl-OC 1-6 alkyl-, halogenated C 1-6 alkyl-; more preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkane Group-, phenyl-C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; particularly preferably H, methyl, ethyl, propyl, isopropyl; most preferably H, methyl; or, when R 2 is connected to a double-bonded carbon atom, R 2 does not exist;
各个n相同或不同,其独立选自1、2、3;或Each n is the same or different, and is independently selected from 1, 2, 3; or
当n=2或3时,在适合的情况下,式(I)的聚醚化合物和式(II)的多环氧化合物中相邻两个碳原子之间任选形成C=C双键,且式(II)的多环氧化合物中的C=C双键 位置与作为产物的式(I)的聚醚化合物中的C=C双键位置相对应;When n=2 or 3, where appropriate, the polyether compound of formula (I) and the polyepoxy compound of formula (II) optionally form a C=C double bond between two adjacent carbon atoms, And the position of the C=C double bond in the polyepoxy compound of formula (II) corresponds to the position of the C=C double bond in the polyether compound of formula (I) as the product;
在式(I)的聚醚化合物以及式(II)的多环氧化合物中,
Figure PCTCN2021099762-appb-000027
片段中碳原子可以任选被以下基团取代:H、OH、C 1-4烷基-、卤代C 1-4烷基-;或
In the polyether compound of formula (I) and the polyepoxy compound of formula (II),
Figure PCTCN2021099762-appb-000027
The carbon atoms in the fragment can be optionally substituted by the following groups: H, OH, C 1-4 alkyl-, halo C 1-4 alkyl-; or
在式(I)的聚醚化合物中,
Figure PCTCN2021099762-appb-000028
部分表示x片段和y片段依次交替重复出现的结构,整个式(I)分子中x片段数目Nx≥1,Nx具体可以为1、2、3、4、5、6、7、8、9、10、11;y片段数目Ny≥0,Ny具体可以为0、1、2、3、4、5、6、7、8、9、10;且1≤Nx+Ny≤20,优选1≤Nx+Ny≤15,更优选1≤Nx+Ny≤10,特别优选1≤Nx+Ny≤8(例如Nx+Ny=1、2、3、4、5、6、7或8),最优选1≤Nx+Ny≤4(例如Nx+Ny=1、2、3或4)。
In the polyether compound of formula (I),
Figure PCTCN2021099762-appb-000028
The part represents the structure where x fragments and y fragments appear alternately and repeatedly, the number of x fragments in the molecule of formula (I) is Nx≥1, and Nx can specifically be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11; the number of y fragments Ny≥0, Ny can specifically be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10; and 1≤Nx+Ny≤20, preferably 1≤Nx +Ny≤15, more preferably 1≤Nx+Ny≤10, particularly preferably 1≤Nx+Ny≤8 (for example, Nx+Ny=1, 2, 3, 4, 5, 6, 7 or 8), most preferably 1 ≤Nx+Ny≤4 (for example, Nx+Ny=1, 2, 3, or 4).
在式(II)的多环氧化合物中,
Figure PCTCN2021099762-appb-000029
部分表示u片段和v片段依次交替重复出现的结构,整个式(II)分子中u片段数目Nu≥1,Nu具体可以为1、2、3、4、5、6、7、8、9、10、11;v片段数目Nv≥0,Nv具体可以为0、1、2、3、4、5、6、7、8、9、10;且1≤Nu+Nv≤20,优选1≤Nu+Nv≤15,更优选1≤Nu+Nv≤10,特别优选1≤Nu+Nv≤8(例如Nu+Nv=1、2、3、4、5、6、7或8),最优选1≤Nu+Nv≤4(例如Nu+Nv=1、2、3或4)。
In the polyepoxy compound of formula (II),
Figure PCTCN2021099762-appb-000029
The part represents the structure where u fragments and v fragments appear alternately and repeatedly, the number of u fragments in the entire formula (II) molecule is Nu≥1, and Nu can be specifically 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11; the number of v fragments Nv≥0, Nv can specifically be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10; and 1≤Nu+Nv≤20, preferably 1≤Nu +Nv≤15, more preferably 1≤Nu+Nv≤10, particularly preferably 1≤Nu+Nv≤8 (for example, Nu+Nv=1, 2, 3, 4, 5, 6, 7 or 8), most preferably 1 ≤Nu+Nv≤4 (for example, Nu+Nv=1, 2, 3, or 4).
且在同一反应中,Nx+Ny=Nu+Nv。And in the same reaction, Nx+Ny=Nu+Nv.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,式(I)所示的反式稠合多聚环醚化合物和式(II)的多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structure of the trans-fused polycyclic ether compound represented by formula (I) and the polyepoxy compound of formula (II) as follows:
Figure PCTCN2021099762-appb-000030
Figure PCTCN2021099762-appb-000030
其中各变量的定义如前述任一方案中所述。The definition of each variable is as described in any of the aforementioned schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,式(I)所示的反式稠合多聚环醚化合物和式(II)的多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structure of the trans-fused polycyclic ether compound represented by formula (I) and the polyepoxy compound of formula (II) as follows:
Figure PCTCN2021099762-appb-000031
Figure PCTCN2021099762-appb-000031
其中各变量的定义如前述任一方案中所述。The definition of each variable is as described in any of the aforementioned schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,式(I)所示的反式稠合多聚环醚化合物和式(II)的多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structure of the trans-fused polycyclic ether compound represented by formula (I) and the polyepoxy compound of formula (II) as follows:
Figure PCTCN2021099762-appb-000032
Figure PCTCN2021099762-appb-000032
其中各变量的定义如前述任一方案中所述。The definition of each variable is as described in any of the aforementioned schemes.
在一些实施方案中,在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与&标记的碳原子连接的
Figure PCTCN2021099762-appb-000033
结构为
Figure PCTCN2021099762-appb-000034
Figure PCTCN2021099762-appb-000035
Figure PCTCN2021099762-appb-000036
(即与右侧结构形成
Figure PCTCN2021099762-appb-000037
),其中a端与环氧基团连接,b端与&标记的碳原子连接;其他
Figure PCTCN2021099762-appb-000038
结构相同或不同,其独立地为
Figure PCTCN2021099762-appb-000039
Figure PCTCN2021099762-appb-000040
c端与左侧基团连接,d端与右侧基团连接;上述
Figure PCTCN2021099762-appb-000041
结构中的每一个氢原子独立地任选被R 4取代;R 4独立地为OH、C 1-4烷基-或卤代C 1-4烷基-,优选甲基、乙基、丙基、异丙基,最优选甲基。
In some embodiments, in some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any of the foregoing embodiments, the
Figure PCTCN2021099762-appb-000033
Structure is
Figure PCTCN2021099762-appb-000034
Figure PCTCN2021099762-appb-000035
Figure PCTCN2021099762-appb-000036
(I.e. form with the structure on the right
Figure PCTCN2021099762-appb-000037
), where the a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
Figure PCTCN2021099762-appb-000038
The structure is the same or different, which are independently
Figure PCTCN2021099762-appb-000039
Figure PCTCN2021099762-appb-000040
The c terminal is connected to the left group, and the d terminal is connected to the right group;
Figure PCTCN2021099762-appb-000041
Each hydrogen atom in the structure is independently optionally substituted by R 4 ; R 4 is independently OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-, preferably methyl, ethyl, propyl , Isopropyl, most preferably methyl.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,各个n相同或不同,其独立选自1、2或3。In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, each n is the same or different, and is independently selected from 1, 2 or 3. .
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,R 3为H。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, R 3 is H.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,R 3为对酸敏感的羟基保护基,例如醚类保护基(例如THP(2-四氢吡喃基))、硅醚保护基(例如TMS(三甲基硅基)或TES(三乙基硅基)),优选为THP、TMS,最优选THP。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, R 3 is an acid-sensitive hydroxyl protecting group, such as an ether protecting group The group (for example, THP (2-tetrahydropyranyl)) and the silyl ether protecting group (for example, TMS (trimethylsilyl) or TES (triethylsilyl)) are preferably THP, TMS, and most preferably THP.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与*标记的碳原子连接的R为C 1-3烷基-,优选甲基、乙基、丙基、异丙基,最优选甲基。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any of the foregoing embodiments, the R connected to the carbon atom marked with * is a C 1-3 alkane Group-, preferably methyl, ethyl, propyl, isopropyl, most preferably methyl.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与*标记的碳原子连接的R 1为C 1-10烷基-,优选C 1-6烷基-,更优选C 1-3烷基-,特别优选甲基、乙基、丙基、异丙基,最优选甲基。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, R 1 connected to the carbon atom marked with * is C 1-10 Alkyl-, preferably C 1-6 alkyl-, more preferably C 1-3 alkyl-, particularly preferably methyl, ethyl, propyl, isopropyl, and most preferably methyl.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与*标记的碳原子连接的R和R 1是相同的。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any of the foregoing embodiments, R and R 1 connected to the carbon atom marked with * are the same .
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与*标记的碳原子连接的R和R 1均为甲基。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any of the foregoing embodiments, R and R 1 connected to the carbon atom marked with * are both methyl base.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,u、v、x和y片段中的R独立地为H或C 1-3烷基-,特别优选H、甲基、乙基、丙基或异丙基,最优选H或甲基。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, R in the u, v, x, and y fragments are independently H Or C 1-3 alkyl-, particularly preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与&标记的碳原子连接的
Figure PCTCN2021099762-appb-000042
结构为
Figure PCTCN2021099762-appb-000043
Figure PCTCN2021099762-appb-000044
其中a端与环氧基团连接,b端与&标记的碳原子连接;其他
Figure PCTCN2021099762-appb-000045
结构相同或不同,其独立地为
Figure PCTCN2021099762-appb-000046
上述
Figure PCTCN2021099762-appb-000047
结构中的每一个氢原子独立地任选被R 4取代。
In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, the
Figure PCTCN2021099762-appb-000042
Structure is
Figure PCTCN2021099762-appb-000043
Figure PCTCN2021099762-appb-000044
The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
Figure PCTCN2021099762-appb-000045
The structure is the same or different, which are independently
Figure PCTCN2021099762-appb-000046
Above
Figure PCTCN2021099762-appb-000047
Each hydrogen atom in the structure is independently optionally substituted by R 4.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与&标记的碳原子连接的
Figure PCTCN2021099762-appb-000048
结构为
Figure PCTCN2021099762-appb-000049
Figure PCTCN2021099762-appb-000050
其中a端与环氧基团连接,b端与&标记的碳原子连接;其他
Figure PCTCN2021099762-appb-000051
结构相同或不同,其独立地为
Figure PCTCN2021099762-appb-000052
上述
Figure PCTCN2021099762-appb-000053
结构中的每一个氢原子独立地任选被R 4取代。
In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, the
Figure PCTCN2021099762-appb-000048
Structure is
Figure PCTCN2021099762-appb-000049
Figure PCTCN2021099762-appb-000050
The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
Figure PCTCN2021099762-appb-000051
The structure is the same or different, which are independently
Figure PCTCN2021099762-appb-000052
Above
Figure PCTCN2021099762-appb-000053
Each hydrogen atom in the structure is independently optionally substituted by R 4.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,通式化合物最左侧的
Figure PCTCN2021099762-appb-000054
结构
Figure PCTCN2021099762-appb-000055
上述
Figure PCTCN2021099762-appb-000056
结构中的每一个氢原子独立地任选被R 4取代;R 4独立地为OH、C 1-4烷基-或卤代C 1-4烷基-,优选C 1-3烷基-,特别优选甲基、乙基、丙基、异丙基,最优选OH、甲基。
In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding schemes, the leftmost compound of the general formula
Figure PCTCN2021099762-appb-000054
structure
Figure PCTCN2021099762-appb-000055
Above
Figure PCTCN2021099762-appb-000056
Each hydrogen atom in the structure is independently optionally substituted by R 4 ; R 4 is independently OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-, preferably C 1-3 alkyl-, Particularly preferred are methyl, ethyl, propyl, and isopropyl, and most preferred are OH and methyl.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,通式化合物最左侧的
Figure PCTCN2021099762-appb-000057
结构为
Figure PCTCN2021099762-appb-000058
In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding schemes, the leftmost compound of the general formula
Figure PCTCN2021099762-appb-000057
Structure is
Figure PCTCN2021099762-appb-000058
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,相邻的x和y片段中的
Figure PCTCN2021099762-appb-000059
结构中的n是不同的。
In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, in the adjacent x and y fragments
Figure PCTCN2021099762-appb-000059
The n in the structure is different.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,R 2为H或C 1-10烷基-,优选H或C 1-6烷基-,更优选H或C 1-3烷基-,特别优选H、甲基、乙基、丙基或异丙基,最优选H或甲基;或者,&标记的碳原子上连接有双键时,则与&标记的碳原子连接的R 2不存在。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, R 2 is H or C 1-10 alkyl-, preferably H Or C 1-6 alkyl-, more preferably H or C 1-3 alkyl-, particularly preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl; or, & marked When a double bond is connected to the carbon atom, R 2 connected to the carbon atom marked with & does not exist.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与&标记的碳原子连接的R 2为H,或者,&标记的碳原子上连接有双键时,则与&标记的碳原子连接的R 2不存在。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, R 2 connected to the carbon atom labeled & is H, or, When a double bond is connected to the carbon atom labeled &, R 2 connected to the carbon atom labeled & does not exist.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与&标记的碳原子连接的R为H或C 1-3烷基-,优选H、甲基、乙基、丙基或异丙基,最优选H或甲基,例如H。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, the R connected to the carbon atom labeled & is H or C 1- 3 Alkyl-, preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl, such as H.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与&标记的碳原子连接的R 2和R为H,或者,&标记的碳原子上连接有双键时,与&标记的碳原子连接的R 2不存在。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any of the foregoing embodiments, R 2 and R connected to the carbon atom labeled & are H, Alternatively, when a double bond is connected to the carbon atom labeled &, R 2 connected to the carbon atom labeled & does not exist.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与#标记的碳原子连接的R为H或C 1-3烷基-,优选H、甲基、乙基、丙基或异丙基,最优选H或甲基。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding schemes, the R connected to the carbon atom marked with # is H or C 1- 3 Alkyl-, preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物 的制备方法中,与#标记的碳原子连接的R 2为H或C 1-10烷基-,优选H或C 1-6烷基-,更优选H或C 1-3烷基-,特别优选H、甲基、乙基、丙基或异丙基,最优选H或甲基。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any one of the preceding embodiments, R 2 connected to the carbon atom marked with # is H or C 1 -10 alkyl-, preferably H or C 1-6 alkyl-, more preferably H or C 1-3 alkyl-, particularly preferably H, methyl, ethyl, propyl or isopropyl, most preferably H or methyl.
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与#标记的碳原子连接的R 2和R是相同的。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any of the foregoing embodiments, R 2 and R connected to the carbon atom labeled with # are the same .
在一些实施方案中,如前述任一方案所述的式(I)所示的反式稠合多聚环醚化合物的制备方法中,与#标记的碳原子连接的R 2和R是相同的且为H或甲基。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound represented by formula (I) as described in any of the foregoing embodiments, R 2 and R connected to the carbon atom labeled with # are the same And is H or methyl.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000060
Figure PCTCN2021099762-appb-000060
其中,R、R 1、R 2、R 3、n定义如上述任一方案中所述。 Wherein, R, R 1 , R 2 , R 3 , and n are defined as described in any of the above schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000061
Figure PCTCN2021099762-appb-000061
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000062
定义如上述任一方案中所述。
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000062
The definition is as described in any of the above schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000063
Figure PCTCN2021099762-appb-000063
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000064
定义如上述任一方案中所述;
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000064
The definition is as described in any of the above schemes;
优选地,
Figure PCTCN2021099762-appb-000065
Figure PCTCN2021099762-appb-000066
例如
Figure PCTCN2021099762-appb-000067
Preferably,
Figure PCTCN2021099762-appb-000065
for
Figure PCTCN2021099762-appb-000066
For example
Figure PCTCN2021099762-appb-000067
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000068
Figure PCTCN2021099762-appb-000068
其中,R、R 1、R 2、R 3、n定义如上。 Wherein, R, R 1 , R 2 , R 3 , and n are as defined above.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000069
Figure PCTCN2021099762-appb-000069
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000070
定义如上述任一方案中所述。
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000070
The definition is as described in any of the above schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000071
Figure PCTCN2021099762-appb-000071
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000072
定义如上述任一方案中所述;
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000072
The definition is as described in any of the above schemes;
优选地,
Figure PCTCN2021099762-appb-000073
结构独立地为
Figure PCTCN2021099762-appb-000074
Preferably,
Figure PCTCN2021099762-appb-000073
The structure is independently
Figure PCTCN2021099762-appb-000074
进一步优选地,u和x片段中的
Figure PCTCN2021099762-appb-000075
结构为
Figure PCTCN2021099762-appb-000076
Further preferably, in the u and x fragments
Figure PCTCN2021099762-appb-000075
Structure is
Figure PCTCN2021099762-appb-000076
进一步优选地,通式最左侧的
Figure PCTCN2021099762-appb-000077
结构为
Figure PCTCN2021099762-appb-000078
Further preferably, the leftmost of the general formula
Figure PCTCN2021099762-appb-000077
Structure is
Figure PCTCN2021099762-appb-000078
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000079
Figure PCTCN2021099762-appb-000079
其中,R、R 1、R 2、R 3、n的定义如上述任一方案中所述。 Wherein, the definitions of R, R 1 , R 2 , R 3 , and n are as described in any of the above schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000080
Figure PCTCN2021099762-appb-000080
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000081
定义如上述任一方案中所述。
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000081
The definition is as described in any of the above schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000082
Figure PCTCN2021099762-appb-000082
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000083
定义如上述任一方案中所述;
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000083
The definition is as described in any of the above schemes;
优选地,
Figure PCTCN2021099762-appb-000084
结构独立地为
Figure PCTCN2021099762-appb-000085
Preferably,
Figure PCTCN2021099762-appb-000084
The structure is independently
Figure PCTCN2021099762-appb-000085
进一步优选地,u和x片段中的
Figure PCTCN2021099762-appb-000086
结构为
Figure PCTCN2021099762-appb-000087
Further preferably, in the u and x fragments
Figure PCTCN2021099762-appb-000086
Structure is
Figure PCTCN2021099762-appb-000087
进一步优选地,v和y片段中的
Figure PCTCN2021099762-appb-000088
结构为
Figure PCTCN2021099762-appb-000089
Further preferably, in the v and y fragments
Figure PCTCN2021099762-appb-000088
Structure is
Figure PCTCN2021099762-appb-000089
进一步优选地,通式最左侧的
Figure PCTCN2021099762-appb-000090
结构为
Figure PCTCN2021099762-appb-000091
Further preferably, the leftmost of the general formula
Figure PCTCN2021099762-appb-000090
Structure is
Figure PCTCN2021099762-appb-000091
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000092
Figure PCTCN2021099762-appb-000092
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000093
定义如上述任一方案中所述;
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000093
The definition is as described in any of the above schemes;
优选地,
Figure PCTCN2021099762-appb-000094
结构独立地为
Figure PCTCN2021099762-appb-000095
Preferably,
Figure PCTCN2021099762-appb-000094
The structure is independently
Figure PCTCN2021099762-appb-000095
进一步优选地,u和x片段中的
Figure PCTCN2021099762-appb-000096
结构为
Figure PCTCN2021099762-appb-000097
Further preferably, in the u and x fragments
Figure PCTCN2021099762-appb-000096
Structure is
Figure PCTCN2021099762-appb-000097
进一步优选地,v和y片段中的
Figure PCTCN2021099762-appb-000098
结构为
Figure PCTCN2021099762-appb-000099
Further preferably, in the v and y fragments
Figure PCTCN2021099762-appb-000098
Structure is
Figure PCTCN2021099762-appb-000099
进一步优选地,通式最左侧的
Figure PCTCN2021099762-appb-000100
结构为
Figure PCTCN2021099762-appb-000101
Further preferably, the leftmost of the general formula
Figure PCTCN2021099762-appb-000100
Structure is
Figure PCTCN2021099762-appb-000101
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000102
Figure PCTCN2021099762-appb-000102
其中,R、R 1、R 2、R 3、n定义如上述任一方案中所述。 Wherein, R, R 1 , R 2 , R 3 , and n are defined as described in any of the above schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000103
Figure PCTCN2021099762-appb-000103
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000104
定义如上述任一方案中所述。
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000104
The definition is as described in any of the above schemes.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structures of the trans-fused polycyclic ether compound and the polyepoxy compound are as follows:
Figure PCTCN2021099762-appb-000105
Figure PCTCN2021099762-appb-000105
其中,R、R 1、R 2、R 3、n、
Figure PCTCN2021099762-appb-000106
定义如上述任一方案中所述;
Among them, R, R 1 , R 2 , R 3 , n,
Figure PCTCN2021099762-appb-000106
The definition is as described in any of the above schemes;
优选地,
Figure PCTCN2021099762-appb-000107
结构独立地为
Figure PCTCN2021099762-appb-000108
Preferably,
Figure PCTCN2021099762-appb-000107
The structure is independently
Figure PCTCN2021099762-appb-000108
进一步优选地,u和x片段中的
Figure PCTCN2021099762-appb-000109
结构为
Figure PCTCN2021099762-appb-000110
Further preferably, in the u and x fragments
Figure PCTCN2021099762-appb-000109
Structure is
Figure PCTCN2021099762-appb-000110
进一步优选地,v和y片段中的
Figure PCTCN2021099762-appb-000111
结构为
Figure PCTCN2021099762-appb-000112
Further preferably, in the v and y fragments
Figure PCTCN2021099762-appb-000111
Structure is
Figure PCTCN2021099762-appb-000112
进一步优选地,通式最左侧的
Figure PCTCN2021099762-appb-000113
结构为
Figure PCTCN2021099762-appb-000114
Further preferably, the leftmost of the general formula
Figure PCTCN2021099762-appb-000113
Structure is
Figure PCTCN2021099762-appb-000114
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,式(I)所示的反式稠合多聚环醚化合物和式(II)的多环氧化合物结构如下:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structure of the trans-fused polycyclic ether compound represented by formula (I) and the polyepoxy compound of formula (II) as follows:
Figure PCTCN2021099762-appb-000115
Figure PCTCN2021099762-appb-000115
u、v、x和y片段中的R独立地为H或甲基;R in the u, v, x and y fragments are independently H or methyl;
与&标记的碳原子连接的
Figure PCTCN2021099762-appb-000116
结构为
Figure PCTCN2021099762-appb-000117
Figure PCTCN2021099762-appb-000118
其中a端与环氧基团连接,b端与&标记的碳原子连接;其他
Figure PCTCN2021099762-appb-000119
结构相同或不同,其独立地为
Figure PCTCN2021099762-appb-000120
Connected to the & marked carbon atom
Figure PCTCN2021099762-appb-000116
Structure is
Figure PCTCN2021099762-appb-000117
Figure PCTCN2021099762-appb-000118
The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
Figure PCTCN2021099762-appb-000119
The structure is the same or different, which are independently
Figure PCTCN2021099762-appb-000120
与#标记的碳原子连接的R 2和R是相同的且为H或甲基; R 2 and R connected to the carbon atom marked with # are the same and are H or methyl;
与&标记的碳原子连接的R 2为H,或者,&标记的碳原子上连接有双键时,则与&标记的碳原子连接的R 2不存在。 R 2 connected to the carbon atom labeled & is H, or when a double bond is connected to the carbon atom labeled &, R 2 connected to the carbon atom labeled & does not exist.
在一些实施方案中,所述的反式稠合多聚环醚化合物的制备方法中,反式稠合多聚环醚化合物和多环氧化合物结构如下任一组:In some embodiments, in the preparation method of the trans-fused polycyclic ether compound, the structure of the trans-fused polycyclic ether compound and the polyepoxy compound is any one of the following groups:
Figure PCTCN2021099762-appb-000121
Figure PCTCN2021099762-appb-000121
Figure PCTCN2021099762-appb-000122
Figure PCTCN2021099762-appb-000122
在一些实施方案中,如上任一方案所述的反式稠合多聚环醚化合物的制备方法中,所述反应介质可为被一个或多个卤素取代的C 1-10烷基醇或其与其他溶剂的混合溶剂。其中,所述被一个或多个卤素取代的C 1-10烷基醇优选为被一个或多个卤素取代的C 1-8烷基醇,更优选为被一个或多个卤素取代的C 1-6烷基醇,特别优选为被一个或多个卤素取代的C 1-4烷基醇;其中卤素选自氟、氯、溴、碘。所述其他溶剂可以选自一个或多个卤素取代的C 1-10烷烃、任选被一个或多个卤素取代的C 1-10醚或环醚、任选被一个或多个卤素取代的C 1-10酯;优选氯仿、二氯甲烷、1,2-二氯乙烷、1,1-二氯乙烷乙醚、四氢呋喃、1,4-二氧六环。 In some embodiments, in the preparation method of the trans-fused polycyclic ether compound as described in any of the above embodiments, the reaction medium may be a C 1-10 alkyl alcohol substituted by one or more halogens or its Mixed solvent with other solvents. Among them, the C 1-10 alkyl alcohol substituted by one or more halogens is preferably C 1-8 alkyl alcohol substituted by one or more halogens , more preferably C 1 substituted by one or more halogens. -6 alkyl alcohol, particularly preferably a C 1-4 alkyl alcohol substituted by one or more halogens; wherein the halogen is selected from fluorine, chlorine, bromine, and iodine. The other solvent may be selected from C 1-10 alkanes substituted with one or more halogens, C 1-10 ethers or cyclic ethers optionally substituted with one or more halogens, C 1-10 optionally substituted with one or more halogens 1-10 esters; preferably chloroform, dichloromethane, 1,2-dichloroethane, 1,1-dichloroethane ethyl ether, tetrahydrofuran, 1,4-dioxane.
在一些实施方案中,如上任一方案所述的反式稠合多聚环醚化合物的制备方法中,所述反应介质最优选为三氟甲醇、三氟乙醇、全氟乙醇、三氟丙醇(包括正丙醇、异丙醇)、六氟丙醇(包括正丙醇、异丙醇)、全氟丙醇(包括正丙醇、异丙醇)、三氟丁醇(包括正丁醇、异丁醇、叔丁醇)、六氟丁醇(包括正丁醇、异丁醇、叔丁醇)、全氟丁醇(包括正丁醇、异丁醇、叔丁醇)、三氟戊醇(包括正戊醇、异戊醇、叔戊醇、新戊醇)、六氟戊醇(包括正戊醇、异戊醇、叔戊醇、新戊醇)、全氟戊醇(包括正戊醇、异戊醇、叔戊醇、新戊醇)、三氟己醇、六氟己醇、全氟己醇。在一些实施方案中,反应介质具体可以为2,2,2-三氟乙醇(TFE)、1,1,1,3,3,3-六氟-2-丙醇(HFIP)、全氟叔丁醇(PFTB),最最优选为全氟叔丁醇(PFTB)。In some embodiments, in the preparation method of the trans-fused polycyclic ether compound as described in any of the above embodiments, the reaction medium is most preferably trifluoromethanol, trifluoroethanol, perfluoroethanol, trifluoropropanol (Including n-propanol, isopropanol), hexafluoropropanol (including n-propanol, isopropanol), perfluoropropanol (including n-propanol, isopropanol), trifluorobutanol (including n-butanol) , Isobutanol, tert-butanol), hexafluorobutanol (including n-butanol, isobutanol, tert-butanol), perfluorobutanol (including n-butanol, isobutanol, tert-butanol), trifluorobutanol Pentanol (including n-pentanol, isoamyl alcohol, tert-amyl alcohol, neopentyl alcohol), hexafluoropentanol (including n-pentanol, isoamyl alcohol, tert-amyl alcohol, neopentyl alcohol), perfluoropentanol (including N-pentanol, isoamyl alcohol, tert-amyl alcohol, neopentyl alcohol), trifluorohexanol, hexafluorohexanol, perfluorohexanol. In some embodiments, the reaction medium may specifically be 2,2,2-trifluoroethanol (TFE), 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), perfluoro tertiary Butanol (PFTB), most preferably perfluoro-tert-butanol (PFTB).
所述含弱配位阴离子的盐可溶于反应介质。The weakly coordinating anion-containing salt is soluble in the reaction medium.
在一些实施方案中,含有弱配位阴离子的盐的阴离子优选为含氟的弱配位阴离子,具体可以为:四氟硼酸阴离子(BF 4 -)、六氟磷酸阴离子(PF 6 -)、六氟锑酸阴离子(SbF 6 -)、三氟甲磺酸阴离子(trifluoromethansulfonate、TfO-)、四[3,5-双(三氟甲基)苯基]硼酸阴离子(tetrakis[3,5-bis(trifluoromethyl)phenyl]borate,(BARF))、四(五氟苯基)硼酸阴离子(tetrakis(pentafluorophenyl)borate);优选四氟硼酸阴离子(BF 4 -)、六氟磷酸阴离子(PF 6 -);最优选四氟硼酸阴离子(BF 4 -)。 In some embodiments, the anionic salt containing weakly coordinating anion is preferably a fluorine-containing weakly coordinating anion, it may be: tetrafluoroborate anion (BF 4 -), hexafluorophosphate anion (PF 6 -), six hexafluoro antimonate anion (SbF 6 -), trifluoromethanesulfonic acid anion (trifluoromethansulfonate, TfO-), tetrakis [3,5-bis (trifluoromethyl) phenyl] borate anion (tetrakis [3,5-bis ( trifluoromethyl) phenyl] borate, (BARF )), tetrakis (pentafluorophenyl) borate anion (tetrakis (pentafluorophenyl) borate); preferably tetrafluoroborate anion (BF 4 -), hexafluorophosphate anion (PF 6 -); most tetrafluoroborate anion (BF 4 -).
在一些实施方案中,含有弱配位阴离子的盐的阳离子可选自季铵离子或季磷离子,例如,四甲基铵离子(Me 4N +)、四乙基铵离子(Et 4N +)、四正丁基铵离子((n-Bu) 4N +)、四苯基季磷离子(Ph 4P +)、1-丁基-3-甲基咪唑季铵离子([BMIM])、1-乙基-3-甲基咪唑季铵离子([EMIM])、1-己基-3-甲基咪唑季铵离子([HMIM]);优选1-丁基-3-甲基咪唑季铵离子([BMIM])、1-乙基-3-甲基咪唑季铵离子([EMIM]);更优选1-乙基-3-甲基咪唑季铵离子([EMIM])。 In some embodiments, the cation of the salt containing weak coordination anion can be selected from quaternary ammonium ion or quaternary phosphorus ion, for example, tetramethylammonium ion (Me 4 N + ), tetraethylammonium ion (Et 4 N + ), tetra-n-butylammonium ion ((n-Bu) 4 N + ), tetraphenyl quaternary phosphonium ion (Ph 4 P + ), 1-butyl-3-methylimidazole quaternary ammonium ion ([BMIM]) , 1-ethyl-3-methylimidazole quaternary ammonium ion ([EMIM]), 1-hexyl-3-methylimidazole quaternary ammonium ion ([HMIM]); preferably 1-butyl-3-methylimidazole quaternary Ammonium ion ([BMIM]), 1-ethyl-3-methylimidazole quaternary ammonium ion ([EMIM]); more preferably 1-ethyl-3-methylimidazole quaternary ammonium ion ([EMIM]).
在一些实施方案中,所述含有弱配位阴离子的盐具体可为[BMIM]BF 4、[BMIM]PF 6、[EMIM]BF 4、[EMIM]PF 6、[HMIM]BF 4、[HMIM]PF 6;优选[BMIM]BF 4、[EMIM]BF 4、[HMIM]BF 4;更优选[EMIM]BF 4In some embodiments, the salt containing weak coordination anions may specifically be [BMIM]BF 4 , [BMIM]PF 6 , [EMIM]BF 4 , [EMIM]PF 6 , [HMIM]BF 4 , [HMIM ]PF 6 ; preferably [BMIM]BF 4 , [EMIM]BF 4 , [HMIM]BF 4 ; more preferably [EMIM]BF 4 .
在一些实施方案中,含有弱配位阴离子的盐与式(II)所示的同手性多环氧化合物的摩尔比可以为1∶10~10∶1,优选1∶5~5∶1,更优选1∶2~2∶1,最优选为1∶1。In some embodiments, the molar ratio of the salt containing the weakly coordinating anion to the homochiral polyepoxy compound represented by formula (II) may be 1:10-10:1, preferably 1:5-5:1, It is more preferably 1:2 to 2:1, most preferably 1:1.
在一些实施方案中,式(II)所示的同手性多环氧化合物在环化反应液中的浓度可以为0.01-2.0mol/L,优选为0.01-1.0mol/L,更优选为0.05-0.5mol/L,最优选为0.1-0.3mol/L。In some embodiments, the concentration of the homochiral polyepoxy compound represented by formula (II) in the cyclization reaction solution may be 0.01-2.0 mol/L, preferably 0.01-1.0 mol/L, more preferably 0.05 -0.5mol/L, most preferably 0.1-0.3mol/L.
在一些实施方案中,环化反应可以在0-100℃(优选10-60℃;更优选20-45℃;最优选40℃)下进行。In some embodiments, the cyclization reaction can be carried out at 0-100°C (preferably 10-60°C; more preferably 20-45°C; most preferably 40°C).
在一些实施方案中,环化反应的时间可以为0.5-24小时,优选为1-18小时,更优选为5-18小时,特别优选为12-18小时,最优选为15小时。In some embodiments, the cyclization reaction time may be 0.5-24 hours, preferably 1-18 hours, more preferably 5-18 hours, particularly preferably 12-18 hours, and most preferably 15 hours.
定义definition
本领域技术人员可以理解的是,本发明中化合物结构中的
Figure PCTCN2021099762-appb-000123
表示相对的立体构型。
Figure PCTCN2021099762-appb-000124
均可以为
Figure PCTCN2021099762-appb-000125
Figure PCTCN2021099762-appb-000126
Figure PCTCN2021099762-appb-000127
时,则
Figure PCTCN2021099762-appb-000128
Figure PCTCN2021099762-appb-000129
Figure PCTCN2021099762-appb-000130
Figure PCTCN2021099762-appb-000131
时,则
Figure PCTCN2021099762-appb-000132
Figure PCTCN2021099762-appb-000133
Those skilled in the art can understand that in the structure of the compound of the present invention,
Figure PCTCN2021099762-appb-000123
Indicates the relative three-dimensional configuration.
Figure PCTCN2021099762-appb-000124
Can be
Figure PCTCN2021099762-appb-000125
when
Figure PCTCN2021099762-appb-000126
for
Figure PCTCN2021099762-appb-000127
时, then
Figure PCTCN2021099762-appb-000128
for
Figure PCTCN2021099762-appb-000129
when
Figure PCTCN2021099762-appb-000130
for
Figure PCTCN2021099762-appb-000131
时, then
Figure PCTCN2021099762-appb-000132
for
Figure PCTCN2021099762-appb-000133
在本发明中,卤素表示氟、氯、溴或碘。In the present invention, halogen means fluorine, chlorine, bromine or iodine.
烷基表示含有1-10个碳原子的直链或支链饱和烃基;优选含有1-8个碳原子的直链或支链饱和烃基;更优选有1-6个碳原子的直链或支链饱和烃基;最优选有1-4个碳原子的直链或支链饱和烃基。烷基的实例包括甲基、乙基、丙基(包括正丙基、异丙基)、丁基(包括正丁基、异丁基、叔丁基)、戊基(包括正戊基、异戊基、叔戊基、新戊基)或己基等。Alkyl represents a straight or branched chain saturated hydrocarbon group containing 1-10 carbon atoms; preferably a straight or branched chain saturated hydrocarbon group containing 1-8 carbon atoms; more preferably a straight chain or branched chain containing 1 to 6 carbon atoms Chain saturated hydrocarbon groups; most preferably straight or branched chain saturated hydrocarbon groups having 1 to 4 carbon atoms. Examples of alkyl groups include methyl, ethyl, propyl (including n-propyl, isopropyl), butyl (including n-butyl, isobutyl, tert-butyl), pentyl (including n-pentyl, isopropyl), Pentyl, tert-pentyl, neopentyl) or hexyl, etc.
烷基醇表示上述烷基中的一个或多个H原子被OH取代的化合物。烷基醇的实例包括甲醇、乙醇、丙醇(包括正丙醇、异丙醇)、丁醇(包括正丁醇、异丁醇、叔丁醇)、戊醇(包括正戊醇、异戊醇、叔戊醇、新戊醇)或己醇等。Alkyl alcohol means a compound in which one or more H atoms in the above-mentioned alkyl group is substituted by OH. Examples of alkyl alcohols include methanol, ethanol, propanol (including n-propanol, isopropanol), butanol (including n-butanol, isobutanol, tert-butanol), pentanol (including n-pentanol, isoamyl alcohol) Alcohol, tert-amyl alcohol, neopentyl alcohol) or hexanol, etc.
卤代醇表示上述烷基醇中的一个或多个H原子被卤素取代的化合物;其中多卤代表 示被2、3、4、5、6、7、8、9、10、11、12、13、14、15、或15个以上的卤素取代,多卤代还表示烷基醇中烷基上的H全部被卤素取代。卤代醇的实例包括三氟甲醇、三氟乙醇、全氟乙醇、三氟丙醇(包括正丙醇、异丙醇)、六氟丙醇(包括正丙醇、异丙醇)、全氟丙醇(包括正丙醇、异丙醇)、三氟丁醇(包括正丁醇、异丁醇、叔丁醇)、六氟丁醇(包括正丁醇、异丁醇、叔丁醇)、全氟丁醇(包括正丁醇、异丁醇、叔丁醇)、三氟戊醇(包括正戊醇、异戊醇、叔戊醇、新戊醇)、六氟戊醇(包括正戊醇、异戊醇、叔戊醇、新戊醇)、全氟戊醇(包括正戊醇、异戊醇、叔戊醇、新戊醇)以及三氟己醇、六氟己醇、全氟己醇等;优选三氟乙醇、六氟丙醇、全氟丁醇;最优选2,2,2-三氟乙醇(TFE)、1,1,1,3,3,3-六氟-2-丙醇(HFIP)、全氟叔丁醇(perfluoro-tert-butanol,PFTB)。Halohydrin refers to a compound in which one or more H atoms in the above-mentioned alkyl alcohol is substituted by halogen; wherein polyhalo refers to 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 15 or more halogens are substituted. Polyhalogenation also means that all H on the alkyl group in the alkyl alcohol is substituted by halogen. Examples of halogenated alcohols include trifluoromethanol, trifluoroethanol, perfluoroethanol, trifluoropropanol (including n-propanol, isopropanol), hexafluoropropanol (including n-propanol, isopropanol), perfluoropropanol Propanol (including n-propanol, isopropanol), trifluorobutanol (including n-butanol, isobutanol, tert-butanol), hexafluorobutanol (including n-butanol, isobutanol, tert-butanol) , Perfluorobutanol (including n-butanol, isobutanol, tert-butanol), trifluoropentanol (including n-pentanol, isoamyl alcohol, tert-amyl alcohol, neopentanol), hexafluoropentanol (including n-pentanol, Amyl alcohol, isoamyl alcohol, tert-amyl alcohol, neopentyl alcohol), perfluoropentanol (including n-amyl alcohol, isoamyl alcohol, tert-amyl alcohol, neopentyl alcohol) and trifluorohexanol, hexafluorohexanol, all Fluorohexanol, etc.; preferably trifluoroethanol, hexafluoropropanol, perfluorobutanol; most preferably 2,2,2-trifluoroethanol (TFE), 1,1,1,3,3,3-hexafluoro- 2-Propanol (HFIP), perfluoro-tert-butanol (PFTB).
所述弱配位阴离子(weakly coordinating anions)是指和阳离子作用力很弱的一类阴离子,所述弱配位阴离子的盐可使反应的碳正离子中间体更加稳定,选择性地生成具有反式稠合多聚环醚骨架的聚醚。The weakly coordinating anions (weakly coordinating anions) refer to a type of anion that has a very weak interaction force with the cation. Formula fused with polycyclic ether backbone polyether.
在不违背本领域常识的基础上,上述各优选条件,可任意组合,即得本发明各较佳实例。On the basis of not violating common knowledge in the field, the above-mentioned preferred conditions can be combined arbitrarily to obtain preferred examples of the present invention.
本发明所用试剂和原料均市售可得。The reagents and raw materials used in the present invention are all commercially available.
有益效果Beneficial effect
本发明的制备方法具有原料易于制备、合成路线短、实验操作简单、反应条件温和、反应快速、收率高等一个或多个优点。例如。本发明的制备方法可以以高达55%的收率得到具有2个反式稠合的环醚的聚醚,以高达57%的收率得到具有3个反式稠合的环醚的聚醚,以高达40%的收率得到具有4个反式稠合的环醚的聚醚,以高达19%的收率得到含有八元环并具有4个反式稠合的环醚的聚醚,以高达17%的收率得到具有brevenal分子中的反式稠合的7/7/6/7/6五环醚骨架的聚醚,所有上述合成反应均只有一步反应。相较于现有的多步有机合成方法而言,本发明为具有反式稠合多聚环醚骨架的聚醚的工业合成提供了更加简易的合成线路,社会效益和经济效应显著,可工业化潜力高。The preparation method of the invention has one or more advantages such as easy preparation of raw materials, short synthetic route, simple experimental operation, mild reaction conditions, rapid reaction and high yield. For example. The preparation method of the present invention can obtain a polyether with 2 trans-fused cyclic ethers at a yield of up to 55%, and obtain a polyether with 3 trans-fused cyclic ethers at a yield of up to 57%, A polyether with 4 trans-fused cyclic ethers was obtained at a yield of up to 40%, and a polyether with an eight-membered ring and 4 trans-fused cyclic ethers was obtained at a yield of up to 19%. The yield is as high as 17% to obtain the polyether with the trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule, and all the above-mentioned synthesis reactions only have one step. Compared with the existing multi-step organic synthesis method, the present invention provides a simpler synthetic route for the industrial synthesis of polyethers with trans-fused polycyclic ether skeletons, which has significant social and economic effects, and can be industrialized. The potential is high.
附图说明Description of the drawings
图1为实施例1所得具有2个反式稠合的环醚的聚醚的核磁共振氢谱图。FIG. 1 is a hydrogen nuclear magnetic resonance spectrum of a polyether with two trans-fused cyclic ethers obtained in Example 1. FIG.
图2为实施例1所得具有2个反式稠合的环醚的聚醚的核磁共振碳谱图。2 is a carbon nuclear magnetic resonance spectrum of the polyether with two trans-fused cyclic ethers obtained in Example 1. FIG.
图3为实施例2所得具有3个反式稠合的环醚的聚醚的核磁共振氢谱图。3 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 2. FIG.
图4为实施例2所得具有3个反式稠合的环醚的聚醚的核磁共振碳谱图。4 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 2. FIG.
图5为实施例3所得具有4个反式稠合的环醚的聚醚的核磁共振氢谱图。5 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3. FIG.
图6为实施例3所得具有4个反式稠合的环醚的聚醚的核磁共振碳谱图。6 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3. FIG.
图7为实施例3所得具有4个反式稠合的环醚的聚醚的高分辨质谱谱图。7 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 3. FIG.
图8为实施例4所得含八元环并具有4个反式稠合的环醚的聚醚的核磁共振氢谱图。FIG. 8 is a hydrogen nuclear magnetic resonance spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4. FIG.
图9为实施例4所得含八元环并具有4个反式稠合的环醚的聚醚的核磁共振碳谱图。9 is a carbon nuclear magnetic resonance spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4. FIG.
图10为实施例4所得含八元环并具有4个反式稠合的环醚的聚醚的高分辨质谱谱图。10 is a high-resolution mass spectrum of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers obtained in Example 4. FIG.
图11为实施例5所得具有brevenal分子中的反式稠合的7/7/6/7/6五环醚骨架的聚醚的核磁共振氢谱图。11 is a hydrogen nuclear magnetic resonance spectrum of the polyether having a trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule obtained in Example 5. FIG.
图12为实施例5所得具有brevenal分子中的反式稠合的7/7/6/7/6五环醚骨架的聚醚的核磁共振碳谱图。Fig. 12 is a carbon nuclear magnetic resonance spectrum of the polyether having a trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule obtained in Example 5.
图13为实施例5所得具有brevenal分子中的反式稠合的7/7/6/7/6五环醚骨架的聚醚的高分辨质谱谱图。13 is a high-resolution mass spectrum of the polyether having a trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule obtained in Example 5.
图14为实施例6所得具有3个反式稠合的环醚的聚醚的核磁共振氢谱图。14 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6. FIG.
图15为实施例6所得具有3个反式稠合的环醚的聚醚的核磁共振碳谱图。15 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6. FIG.
图16为实施例6所得具有3个反式稠合的环醚的聚醚的高分辨质谱谱图。16 is a high-resolution mass spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 6. FIG.
图17为实施例7所得具有3个反式稠合的环醚的聚醚的核磁共振氢谱图。FIG. 17 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 7. FIG.
图18为实施例7所得具有3个反式稠合的环醚的聚醚的核磁共振碳谱图。18 is a carbon nuclear magnetic resonance spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 7. FIG.
图19为实施例7所得具有3个反式稠合的环醚的聚醚的高分辨质谱谱图。19 is a high-resolution mass spectrum of the polyether with 3 trans-fused cyclic ethers obtained in Example 7. FIG.
图20为实施例8所得具有4个反式稠合的环醚的聚醚的核磁共振氢谱图。20 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8. FIG.
图21为实施例8所得具有4个反式稠合的环醚的聚醚的核磁共振碳谱图。21 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8. FIG.
图22为实施例8所得具有4个反式稠合的环醚的聚醚的高分辨质谱谱图。22 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 8. FIG.
图23为实施例9所得具有4个反式稠合的环醚的聚醚的核磁共振氢谱图。FIG. 23 is a hydrogen nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9. FIG.
图24为实施例9所得具有4个反式稠合的环醚的聚醚的核磁共振碳谱图。24 is a carbon nuclear magnetic resonance spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9. FIG.
图25为实施例9所得具有4个反式稠合的环醚的聚醚的高分辨质谱谱图。25 is a high-resolution mass spectrum of the polyether with 4 trans-fused cyclic ethers obtained in Example 9.
具体实施方式detailed description
下面结合具体实施例对本发明进一步说明,用以帮助于对本发明的理解,但本发明的保护范围不限于以下实施例。The present invention will be further described below in conjunction with specific embodiments to help the understanding of the present invention, but the protection scope of the present invention is not limited to the following embodiments.
本申请实施例中所用环氧化化合物均由相应的烯类化合物经本领域公知的Shi不对称环氧化反应制备得到(具体可参照文献Angew.Chem.Int.Ed.2020,59,pp 18473-18478.; Org.Lett.2012,14,pp 3932-3935;Science 2007,317,pp 1189-1192;J.Am.Chem.Soc.2005,127,pp 4586-4587),其中Shi不对称环氧化反应条件均是本领域常规反应条件。The epoxidized compounds used in the examples of this application are all prepared from the corresponding olefinic compounds through the Shi asymmetric epoxidation reaction known in the art (for details, please refer to the document Angew.Chem.Int.Ed.2020, 59, pp 18473 -18478.; Org. Lett. 2012, 14, pp 3932-3935; Science 2007, 317, pp 1189-1192; J. Am. Chem. Soc. 2005, 127, pp 4586-4587), in which Shi asymmetric ring The oxidation reaction conditions are all conventional reaction conditions in the art.
实施例1:Example 1:
Figure PCTCN2021099762-appb-000134
Figure PCTCN2021099762-appb-000134
将由Shi不对称环氧化得到的二环氧醇的非对映体混合物(48.4mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的二环氧醇的含量为89%,即0.178mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应15小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(23.7mg,收率55%),即为具有2个环的反式稠合的多聚环醚。对其进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图1所示,核磁共振碳谱图如图2所示。 The diastereomer mixture of diepoxy alcohol obtained by Shi asymmetric epoxidation (48.4 mg, 0.2 mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of all diepoxy alcohols (R, R) is 89%, That is, 0.178mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C for 15 hours . After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, separated to obtain a white solid (23.7mg, yield 55%), which is A trans-fused polycyclic ether with 2 rings. After 1 H NMR, 13 C NMR and mass spectrometry analysis, the obtained proton nuclear magnetic resonance spectrum is shown in Fig. 1, and the carbon nuclear magnetic resonance spectrum is shown in Fig. 2.
具有2个反式稠合的环醚的聚醚的分析数据:Analytical data of polyether with 2 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ3.81(dd,J=6.3,4.1Hz,1H),3.64(dd,J=11.7,4.4Hz,1H),1.93-1.78(m,3H),1.71-1.65(m,1H),1.62-1.56(m,2H),1.56-1.45(m,2H),1.28(s,3H),1.25(s,3H),1.24(s,3H),1.18(s,3H),1.12(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 3.81 (dd, J = 6.3, 4.1 Hz, 1H), 3.64 (dd, J = 11.7, 4.4 Hz, 1H), 1.93-1.78 (m, 3H), 1.71 1.65(m, 1H), 1.62-1.56(m, 2H), 1.56-1.45(m, 2H), 1.28(s, 3H), 1.25(s, 3H), 1.24(s, 3H), 1.18(s, 3H), 1.12(s, 3H);
13C NMR(100MHz,CDCl 3)δ78.1,76.6,76.5,73.5,71.0,37.3,36.2,33.2,28.8,27.2,25.5,25.0,22.1,19.9; 13 C NMR (100MHz, CDCl 3 ) δ 78.1, 76.6, 76.5, 73.5, 71.0, 37.3, 36.2, 33.2, 28.8, 27.2, 25.5, 25.0, 22.1, 19.9;
HRMS(ESI):m/z C 14H 27O 3[M+H] +计算值243,1955,实测值243.1957. HRMS(ESI): m/z C 14 H 27 O 3 [M+H] + calculated value 243, 1955, measured value 243.1957.
实施例2:Example 2:
Figure PCTCN2021099762-appb-000135
Figure PCTCN2021099762-appb-000135
将由Shi不对称环氧化得到的三环氧醇的非对映体混合物(59.6mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的三环氧醇的底物的含量为83%,即0.166mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol), 在40℃下搅拌反应15小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(28.2mg,收率57%)即为具有3个环的反式稠合的多聚环醚。对其进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图3所示,核磁共振碳谱图如图4所示。 The diastereomer mixture of triepoxy alcohol obtained by Shi asymmetric epoxidation (59.6mg, 0.2mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of the substrate of triepoxy alcohol which is all (R, R) is 83%, ie 0.166mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and stirred at 40°C React for 15 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, separated to obtain a white solid (28.2mg, yield 57%), which is 3-ring trans-fused polycyclic ether. After 1 H NMR, 13 C NMR and mass spectrometry analysis, the obtained proton nuclear magnetic resonance spectrum is shown in Fig. 3, and the carbon nuclear magnetic resonance spectrum is shown in Fig. 4.
具有3个反式稠合的环醚的聚醚的分析数据:Analytical data of polyether with 3 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ3.76(s,1H),3.63-3.48(m,4H),2.11-1.90(m,2H),1.85-1.78(m,3H),1.66-1.57(m,4H),1.54-1.41(m,3H),1.25(s,3H),1.24(s,3H),1.23(s,3H),1.09(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 3.76 (s, 1H), 3.63-3.48 (m, 4H), 2.11-1.90 (m, 2H), 1.85-1.78 (m, 3H), 1.66-1.57 (m , 4H), 1.54-1.41(m, 3H), 1.25(s, 3H), 1.24(s, 3H), 1.23(s, 3H), 1.09(s, 3H);
13C NMR(100MHz,CDCl 3)δ78.9,78.1,77.7,77.1,76.6,70.4,60.7,40.3,35.8,28.91,28.87,27.5,26.3,25.6,21.5,18.6,16.3; 13 C NMR (100MHz, CDCl 3 ) δ 78.9, 78.1, 77.7, 77.1, 76.6, 70.4, 60.7, 40.3, 35.8, 28.91, 28.87, 27.5, 26.3, 25.6, 21.5, 18.6, 16.3;
HRMS(ESI):m/z C 17H 30O 4Na[M+Na] +计算值321.2036,实测值321.2036. HRMS (ESI): m/z C 17 H 30 O 4 Na[M+Na] + calculated value 321.2036, measured value 321.2036.
实施例3:Example 3:
Figure PCTCN2021099762-appb-000136
Figure PCTCN2021099762-appb-000136
将由Shi不对称环氧化得到的四环氧醇的非对映体混合物(73.6mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的四环氧醇底物的含量为75%,即0.15mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应15小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(22.1mg,收率40%)即为具有4个环的反式稠合的多聚环醚。对其进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图5所示,核磁共振碳谱图如图6所示,高分辨质谱谱图如图7所示。 The diastereomer mixture of tetraepoxy alcohol obtained by Shi asymmetric epoxidation (73.6mg, 0.2mmol, according to the proton nuclear magnetic spectrum analysis, the content of the tetraepoxy alcohol substrate which is all (R, R) is 75 %, ie 0.15mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C 15 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, the white solid (22.1mg, yield 40%) is obtained 4-ring trans-fused polycyclic ether. After 1 H NMR, 13 C NMR and mass spectrometry analysis, the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 5, the carbon nuclear magnetic resonance spectrum is shown in FIG. 6, and the high-resolution mass spectrum spectrum is shown in FIG. 7.
具有4个反式稠合的环醚的聚醚的分析数据:Analytical data of polyether with 4 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ3.81(t,J=8.4Hz,1H),3.75(d,J=5.9Hz,1H),3.65(dd,J=11.7Hz,2.2Hz,2H),3.61-3.56(m,1H),3.29(dd,J=11.7Hz,3.9Hz,1H),2.02-1.93(m,2H),1.88-1.83(m,2H),1.82-1.80(m,1H),1.79-1.75(m,2H),1.70-1.66(m,2H),1.65-1.62(m, 2H),1.52-1.46(m,4H),1.30(s,3H),1.24(s,3H),1.23(s,6H),1.09(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 3.81 (t, J = 8.4 Hz, 1H), 3.75 (d, J = 5.9 Hz, 1H), 3.65 (dd, J = 11.7 Hz, 2.2 Hz, 2H), 3.61-3.56(m, 1H), 3.29(dd, J=11.7Hz, 3.9Hz, 1H), 2.02-1.93(m, 2H), 1.88-1.83(m, 2H), 1.82-1.80(m, 1H) , 1.79-1.75(m, 2H), 1.70-1.66(m, 2H), 1.65-1.62(m, 2H), 1.52-1.46(m, 4H), 1.30(s, 3H), 1.24(s, 3H) , 1.23(s, 6H), 1.09(s, 3H);
13C NMR(100MHz,CDCl 3)δ79.1,78.5,77.7,76.6,76.4,73.4,72.8,68.5,59.8,42.6,39.4,35.8,29.2,28.9,26.0,25.6,24.4,21.4,20.3,16.1,14.6; 13 C NMR (100MHz, CDCl 3 ) δ 79.1, 78.5, 77.7, 76.6, 76.4, 73.4, 72.8, 68.5, 59.8, 42.6, 39.4, 35.8, 29.2, 28.9, 26.0, 25.6, 24.4, 21.4, 20.3, 16.1 , 14.6;
HRMS(ESI)m/z C 21H 36O 5Na[M+Na] +计算值391.2455,实测值391.2460. HRMS (ESI) m/z C 21 H 36 O 5 Na[M+Na] + calculated value 391.2455, measured value 391.2460.
实施例4:Example 4:
Figure PCTCN2021099762-appb-000137
Figure PCTCN2021099762-appb-000137
将由Shi不对称环氧化得到的含有顺式二取代烯烃的四环氧醇的非对映体混合物(78.9mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的四环氧醇底物的含量为75%,即0.15mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应15小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(11.2mg,收率19%)即为具有八元环醚的4个环的反式稠合的多聚环醚。对其进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图8所示,核磁共振碳谱图如图9所示,高分辨质谱谱图如图10所示。 The diastereomeric mixture of tetraepoxy alcohol containing cis-disubstituted olefins obtained by Shi asymmetric epoxidation (78.9 mg, 0.2 mmol, according to the analysis of hydrogen nuclear magnetic spectrum, all of which are (R, R) tetraepoxy The content of the alcohol substrate is 75%, that is, 0.15mmol) is dissolved in perfluoro-tert-butanol (2mL), and then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) is added to it , The reaction was stirred at 40°C for 15 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, separated to obtain a white solid (11.2mg, yield 19%) is The 4-ring trans-fused polycyclic ether of eight-membered cyclic ether. After 1 H NMR, 13 C NMR and mass spectrometry analysis, the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 8, the carbon nuclear magnetic resonance spectrum is shown in FIG. 9, and the high-resolution mass spectrum spectrum is shown in FIG. 10.
含八元环并具有4个反式稠合的环醚的聚醚的分析数据:Analytical data of a polyether containing an eight-membered ring and having 4 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ5.65-5.58(m,1H),5.40-5.37(m,1H),4.40-4.35(m,1H),4.22-4.17(m,1H),3.84(t,J=8.0Hz,1H),3.76-3.72(m,2H),3.62(dd,J=11.5Hz,2.5Hz,1H),2.15(t,J=12.1Hz,1H),2.01-1.93(m,2H),1.89-1.79(m,4H),1.64-1.58(m,5H),1.51-1.42(m,3H),1.32(s,3H),1.25(s,9H),1.09(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 5.65-5.58 (m, 1H), 5.40-5.37 (m, 1H), 4.40-4.35 (m, 1H), 4.22-4.17 (m, 1H), 3.84 (t , J=8.0Hz, 1H), 3.76-3.72(m, 2H), 3.62(dd, J=11.5Hz, 2.5Hz, 1H), 2.15(t, J=12.1Hz, 1H), 2.01-1.93(m , 2H), 1.89-1.79(m, 4H), 1.64-1.58(m, 5H), 1.51-1.42(m, 3H), 1.32(s, 3H), 1.25(s, 9H), 1.09(s, 3H) );
13C NMR(100MHz,CDCl 3)δ131.1,125.9,79.2,77.7,77.4,77.2,76.5,69.2,68.5,63.0,39.4,37.0,35.8,30.0,29.2,28.9,25.6,21.8,21.4,21.0,19.6,16.2; 13 C NMR (100MHz, CDCl 3 ) δ 131.1, 125.9, 79.2, 77.7, 77.4, 77.2, 76.5, 69.2, 68.5, 63.0, 39.4, 37.0, 35.8, 30.0, 29.2, 28.9, 25.6, 21.8, 21.4, 21.0 , 19.6, 16.2;
HRMS(ESI)m/z C 23H 38O 5Na[M+Na] +计算值417.2611,实测值417.2615. HRMS (ESI) m/z C 23 H 38 O 5 Na[M+Na] + calculated value 417.2611, measured value 417.2615.
实施例5:Example 5:
Figure PCTCN2021099762-appb-000138
Figure PCTCN2021099762-appb-000138
将由Shi不对称环氧化得到的五环氧醇的非对映体混合物(90.5mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的五环氧醇底物的含量为71%,即0.142mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应15小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(10.9mg,收率17%)即为具有5个环的反式稠合的多聚环醚。对其进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图11所示,核磁共振碳谱图如图12所示,高分辨质谱谱图如图13所示。 The diastereomer mixture of pentaepoxy alcohol obtained by Shi asymmetric epoxidation (90.5mg, 0.2mmol, according to the proton nuclear magnetic spectrum analysis, the content of all (R, R) pentaepoxy alcohol substrate is 71 %, that is, 0.142mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C. 15 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, the white solid (10.9mg, yield 17%) is obtained. 5-ring trans-fused polycyclic ether. After 1 H NMR, 13 C NMR and mass spectrometry analysis, the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 11, the carbon nuclear magnetic resonance spectrum is shown in FIG. 12, and the high-resolution mass spectrum is shown in FIG. 13.
具有brevenal分子中的反式稠合的7/7/6/7/6五环醚骨架的聚醚的分析数据:Analytical data of polyether with trans-fused 7/7/6/7/6 pentacyclic ether skeleton in brevenal molecule:
1H NMR(400MHz,CDCl 3)δ3.75-3.71(m,1H),3.70-3.66(m,1H),3.62(dd,J=11.4Hz,2.1Hz,1H),3.52(d,J=3.8Hz,1H),3.49(d,J=3.4Hz,1H),3.47(d,J=3.9Hz,1H),3.44-3.40(m,1H),2.01-1.89(m,3H),1.81-1.75(m,5H),1.73-1.66(m,3H),1.65-1.55(m,6H),1.48-1.42(m,2H),1.26(s,3H),1.234(s,3H),1.227(s,3H),1.217(s,6H),1.08(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 3.75-3.71 (m, 1H), 3.70-3.66 (m, 1H), 3.62 (dd, J=11.4Hz, 2.1Hz, 1H), 3.52 (d, J= 3.8Hz, 1H), 3.49(d, J=3.4Hz, 1H), 3.47(d, J=3.9Hz, 1H), 3.44-3.40(m, 1H), 2.01-1.89(m, 3H), 1.81- 1.75 (m, 5H), 1.73-1.66 (m, 3H), 1.65-1.55 (m, 6H), 1.48-1.42 (m, 2H), 1.26 (s, 3H), 1.234 (s, 3H), 1.227 ( s, 3H), 1.217 (s, 6H), 1.08 (s, 3H);
13C NMR(100MHz,CDCl 3)δ78.9,77.7,77.3,77.1,76.7,76.5,76.3,74.0,72.6,68.3,60.1,43.6,39.2,39.0,35.8,29.2,28.9,27.4,26.1,25.73,25.65,21.3,19.8,17.0,16.2,15.9; 13 C NMR (100MHz, CDCl 3 ) δ 78.9, 77.7, 77.3, 77.1, 76.7, 76.5, 76.3, 74.0, 72.6, 68.3, 60.1, 43.6, 39.2, 39.0, 35.8, 29.2, 28.9, 27.4, 26.1, 25.73 , 25.65, 21.3, 19.8, 17.0, 16.2, 15.9;
HRMS(ESI)m/z C 26H 44O 6Na[M+Na] +计算值475.3030,实测值475.3035。 HRMS (ESI) m/z C 26 H 44 O 6 Na[M+Na] + Calculated value 475.3030, actual value 475.3035.
实施例6:Example 6:
Figure PCTCN2021099762-appb-000139
Figure PCTCN2021099762-appb-000139
将由Shi不对称环氧化得到的三环氧醇的非对映体混合物(54.0mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的三环氧醇的底物的含量为83%,即0.166mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应24小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再 用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(20.2mg,收率45%)即为具有3个环的反式稠合的多聚环醚。对其进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图14所示,核磁共振碳谱图如图15所示,高分辨质谱谱图如图16所示。 The diastereomeric mixture of triepoxy alcohol obtained by Shi asymmetric epoxidation (54.0 mg, 0.2 mmol, and the content of the substrate of triepoxy alcohol which is all (R, R) according to the proton nuclear magnetic spectrum analysis is 83%, ie 0.166mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and stirred at 40°C React for 24 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, the white solid (20.2mg, yield 45%) is obtained. 3-ring trans-fused polycyclic ether. After 1 H NMR, 13 C NMR and mass spectrometry analysis, the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 14, the carbon nuclear magnetic resonance spectrum is shown in FIG. 15, and the high-resolution mass spectrum spectrum is shown in FIG. 16.
具有3个反式稠合的环醚的聚醚的分析数据:Analytical data of polyether with 3 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ3.86-3.72(m,2H),3.69-3.55(m,2H),3.25-3.15(m,1H),3.11(dd,J=11.9Hz,3.8Hz,1H),1.93-1.81(m,5H),1.78-1.72(m,1H),1.71-1.62(m,3H),1.56-1.50(m,1H),1.43(t,J=11.6Hz,1H),1.26(s,3H),1.20(s,3H),1.11(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 3.86-3.72 (m, 2H), 3.69-3.55 (m, 2H), 3.25-3.15 (m, 1H), 3.11 (dd, J = 11.9 Hz, 3.8 Hz, 1H), 1.93-1.81 (m, 5H), 1.78-1.72 (m, 1H), 1.71-1.62 (m, 3H), 1.56-1.50 (m, 1H), 1.43 (t, J=11.6Hz, 1H) , 1.26(s, 3H), 1.20(s, 3H), 1.11(s, 3H);
13C NMR(100MHz,CDCl 3)δ82.5,79.7,77.7,75.8,72.6,70.1,59.8,46.4,28.7,25.85,25.82,24.7,24.3,21.6,14.9; 13 C NMR (100MHz, CDCl 3 ) δ 82.5, 79.7, 77.7, 75.8, 72.6, 70.1, 59.8, 46.4, 28.7, 25.85, 25.82, 24.7, 24.3, 21.6, 14.9;
HRMS(ESI):m/z C 15H 27O 4[M+H] +计算值271.1909,实测值271.1903. HRMS(ESI): m/z C 15 H 27 O 4 [M+H] + calculated value 271.1909, measured value 271.1903.
实施例7:Example 7:
Figure PCTCN2021099762-appb-000140
Figure PCTCN2021099762-appb-000140
将由Shi不对称环氧化得到的三环氧醇的非对映体混合物(51.2mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的三环氧醇的底物的含量为83%,即0.166mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应24小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(11.5mg,收率27%)即为具有3个环的反式稠合的多聚环醚。The diastereomer mixture of triepoxy alcohol obtained by Shi asymmetric epoxidation (51.2 mg, 0.2 mmol, according to the proton nuclear magnetic spectrum analysis, the content of the substrate of triepoxy alcohol which is all (R, R) is 83%, ie 0.166mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and stirred at 40°C React for 24 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , Then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, the white solid (11.5mg, yield 27%) was obtained 3-ring trans-fused polycyclic ether.
当将三环氧醇的羟基保护为对酸性条件敏感的保护基时,由羟基进攻环氧引发的从右向左的环化会进一步得到抑制,在完全相同的反应条件下,全endo环化的产品的收率会提高到52%。将由Shi不对称环氧化得到的THP保护羟基的三环氧的非对映体混合物(68.0mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的三环氧的底物的含量为83%,即0.166mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四 氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应24小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(22.1mg,收率52%)即为具有3个环的反式稠合的多聚环醚。When the hydroxyl group of triepoxy alcohol is protected as a protective group sensitive to acidic conditions, the right-to-left cyclization initiated by the attack of the hydroxyl group on the epoxy will be further inhibited. Under the same reaction conditions, full endo cyclization The yield of the product will increase to 52%. The diastereomer mixture of THP-protected hydroxyl triepoxy obtained by Shi asymmetric epoxidation (68.0mg, 0.2mmol, according to the proton nuclear magnetic spectrum analysis, all of which are (R, R) triepoxy substrates The content is 83%, that is, 0.166mmol) is dissolved in perfluoro-tert-butanol (2mL), and then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) is added to it, at 40℃ The reaction was stirred for 24 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, separated to obtain a white solid (22.1mg, yield 52%), which is 3-ring trans-fused polycyclic ether.
对产物进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图17所示,核磁共振碳谱图如图18所示,高分辨质谱谱图如图19所示。 The product was analyzed by 1 H NMR, 13 C NMR and mass spectrometry. The obtained proton nuclear magnetic resonance spectrum is shown in FIG. 17, the carbon nuclear magnetic resonance spectrum is shown in FIG. 18, and the high-resolution mass spectrum spectrum is shown in FIG. 19.
具有3个反式稠合的环醚的聚醚的分析数据:Analytical data of polyether with 3 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ3.92-3.86(m,1H),3.82-3.77(m,1H),3.71-3.63(m,1H),3.41-3.31(m,1H),3.22-3.10(m,1H),3.02-2.89(m,2H),2.16-2.08(m,1H),2.07-2.00(m,1H),1.90-1.81(m,4H),1.72-1.64(m,3H),1.44-1.35(m,2H),1.27(s,3H),1.12(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ3.92-3.86 (m, 1H), 3.82-3.77 (m, 1H), 3.71-3.63 (m, 1H), 3.41-3.31 (m, 1H), 3.22-3.10 (m, 1H), 3.02-2.89 (m, 2H), 2.16-2.08 (m, 1H), 2.07-2.00 (m, 1H), 1.90-1.81 (m, 4H), 1.72-1.64 (m, 3H) , 1.44-1.35(m, 2H), 1.27(s, 3H), 1.12(s, 3H);
13C NMR(100MHz,CDCl 3)δ81.0,77.8,76.89,76.83,75.8,70.1,67.7,38.3,29.3,28.7,25.8,25.4,24.7,21.4; 13 C NMR (100MHz, CDCl 3 ) δ 81.0, 77.8, 76.89, 76.83, 75.8, 70.1, 67.7, 38.3, 29.3, 28.7, 25.8, 25.4, 24.7, 21.4;
HRMS(ESI)m/z C 14H 25O 4[M+H] +计算值257.1753,实测值257.1749. HRMS(ESI)m/z C 14 H 25 O 4 [M+H] + calculated value 257.1753, measured value 257.1749.
实施例8:Example 8:
Figure PCTCN2021099762-appb-000141
Figure PCTCN2021099762-appb-000141
将由Shi不对称环氧化得到的四环氧醇的非对映体混合物(70.8mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的四环氧醇底物的含量为75%,即0.15mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应24小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到白色固体(11.2mg,收率21%)即为具有4个环的反式稠合的多聚环醚。对其进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图20所示,核磁共振碳谱图如图21所示,高分辨质谱谱图如图22所示。 The diastereomer mixture of tetraepoxy alcohol obtained by Shi asymmetric epoxidation (70.8 mg, 0.2 mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of which is all (R, R) tetraepoxy alcohol substrate is 75 %, ie 0.15mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C 24 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , And then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, the white solid (11.2mg, yield 21%) was obtained. 4-ring trans-fused polycyclic ether. After 1 H NMR, 13 C NMR and mass spectrometry were performed, the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 20, the carbon nuclear magnetic resonance spectrum is shown in FIG. 21, and the high-resolution mass spectrum spectrum is shown in FIG. 22.
具有4个反式稠合的环醚的聚醚的分析数据:Analytical data of polyether with 4 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ3.90-3.87(m,1H),3.75(d,J=5.0Hz,1H),3.68(dd,J= 11.9Hz,4.3Hz,1H),3.61(dd,J=11.4Hz,2.4Hz,1H),3.40-3.32(m,1H),3.20-3.14(m,1H),2.96-2.90(m,1H),2.00-1.93(m,3H),1.91-1.84(m,3H),1.82-1.79(m,3H),1.70-1.64(m,3H),1.52-1.42(m,3H),1.27(s,3H),1.24(s,6H),1.09(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 3.90-3.87 (m, 1H), 3.75 (d, J = 5.0 Hz, 1H), 3.68 (dd, J = 11.9 Hz, 4.3 Hz, 1H), 3.61 (dd , J=11.4Hz, 2.4Hz, 1H), 3.40-3.32 (m, 1H), 3.20-3.14 (m, 1H), 2.96-2.90 (m, 1H), 2.00-1.93 (m, 3H), 1.91 1.84(m, 3H), 1.82-1.79(m, 3H), 1.70-1.64(m, 3H), 1.52-1.42(m, 3H), 1.27(s, 3H), 1.24(s, 6H), 1.09( s, 3H);
13C NMR(100MHz,CDCl 3)δ79.2,78.4,77.7,77.6,77.2,76.5,70.6,69.2,67.9,39.5,35.7,34.1,29.9,29.0,28.9,25.73,25.64,21.5,19.8,16.2; 13 C NMR (100MHz, CDCl 3 ) δ 79.2, 78.4, 77.7, 77.6, 77.2, 76.5, 70.6, 69.2, 67.9, 39.5, 35.7, 34.1, 29.9, 29.0, 28.9, 25.73, 25.64, 21.5, 19.8, 16.2 ;
HRMS(ESI)m/z C 20H 34O 5Na[M+Na] +计算值377.2298,实测值377.2302. HRMS (ESI) m/z C 20 H 34 O 5 Na[M+Na] + calculated value 377.2298, measured value 377.2302.
实施例9:Example 9:
Figure PCTCN2021099762-appb-000142
Figure PCTCN2021099762-appb-000142
将由Shi不对称环氧化得到的四环氧醇的非对映体混合物(68.0mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的四环氧醇底物的含量为75%,即0.15mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应20小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到无色油状(9.7mg,收率19%)即为具有4个环的反式稠合的多聚环醚。The diastereomer mixture of tetraepoxy alcohol obtained by Shi asymmetric epoxidation (68.0mg, 0.2mmol, according to the hydrogen nuclear magnetic spectrum analysis, the content of all tetraepoxy alcohol substrates of (R, R) is 75 %, ie 0.15mmol) was dissolved in perfluoro-tert-butanol (2mL), then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, and the reaction was stirred at 40°C 20 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , Then dried with anhydrous magnesium sulfate, filtered and concentrated, used 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, separated to obtain a colorless oil (9.7mg, yield 19%) that is A trans-fused polycyclic ether with 4 rings.
当将四环氧醇的羟基保护为对酸性条件敏感的保护基时,由羟基进攻环氧引发的从右向左的环化会进一步得到抑制,在完全相同的反应条件下,全endo环化的产品的收率会提高到32%。将由Shi不对称环氧化得到的THP保护羟基的四环氧的非对映体混合物(84.9mg,0.2mmol,根据核磁氢谱分析其中全部是(R,R)的四环氧底物的含量为75%,即0.15mmol)溶于全氟叔丁醇(2mL)中,再向其中加入1-乙基-3-甲基咪唑四氟硼酸盐(40mg,0.2mmol),在40℃下搅拌反应20小时。反应完毕后加入水(5mL)淬灭反应,反应混合物用二氯甲烷萃取三次,每次10mL,合并三次萃取的有机相,有机相用水(10mL)洗一次,再用食盐水(10mL)洗一次,然后用无水硫酸镁干燥,过滤浓缩,使用35-50%的乙酸乙酯/石油醚作为洗脱剂进行硅胶柱层析,分离得到无色油状(16.3mg,收率32%)即为具有4个环的反式稠合的多聚环醚。When the hydroxyl group of tetraepoxy alcohol is protected as a protective group sensitive to acidic conditions, the right-to-left cyclization initiated by the attack of the hydroxyl group on the epoxy will be further inhibited. Under the same reaction conditions, full endo cyclization The yield of the product will increase to 32%. The diastereomer mixture of THP-protected hydroxyl tetraepoxy obtained by Shi asymmetric epoxidation (84.9mg, 0.2mmol, according to the hydrogen nuclear magnetic spectrum analysis of the content of all (R, R) tetraepoxy substrates 75%, ie 0.15mmol) was dissolved in perfluoro-tert-butanol (2mL), and then 1-ethyl-3-methylimidazole tetrafluoroborate (40mg, 0.2mmol) was added to it, at 40℃ The reaction was stirred for 20 hours. After the reaction was completed, water (5mL) was added to quench the reaction. The reaction mixture was extracted three times with dichloromethane, 10mL each time. The organic phases from the three extractions were combined. The organic phase was washed once with water (10mL) and then with brine (10mL) once. , Then dried with anhydrous magnesium sulfate, filtered and concentrated, using 35-50% ethyl acetate/petroleum ether as the eluent for silica gel column chromatography, separated to obtain a colorless oil (16.3mg, yield 32%) that is A trans-fused polycyclic ether with 4 rings.
对产物进行 1H NMR、 13C NMR和质谱分析,所得核磁共振氢谱如图23所示,核磁共振碳谱图如图24所示,高分辨质谱谱图如图25所示。 The product was analyzed by 1 H NMR, 13 C NMR and mass spectrometry, and the obtained proton nuclear magnetic resonance spectrum is shown in FIG. 23, the carbon nuclear magnetic resonance spectrum is shown in FIG. 24, and the high-resolution mass spectrum spectrum is shown in FIG. 25.
具有4个反式稠合的环醚的聚醚的分析数据:Analytical data of polyether with 4 trans-fused cyclic ethers:
1H NMR(400MHz,CDCl 3)δ3.90-3.81(m,3H),3.78-3.75(m,1H),3.74-3.68(m,2H),3.67-3.62(m,1H),3.12-3.01(m,1H),2.50-2.39(m,1H),1.99-1.94(m,1H),1.90-1.85(m,3H),1.84-1.79(m,5H),1.78-1.70(m,3H),1.65-1.61(m,1H),1.38-1.31(m,1H),1.26(s,3H),1.12(s,3H),1.10(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ 3.90-3.81 (m, 3H), 3.78-3.75 (m, 1H), 3.74-3.68 (m, 2H), 3.67-3.62 (m, 1H), 3.12-3.01 (m, 1H), 2.50-2.39 (m, 1H), 1.99-1.94 (m, 1H), 1.90-1.85 (m, 3H), 1.84-1.79 (m, 5H), 1.78-1.70 (m, 3H) , 1.65-1.61 (m, 1H), 1.38-1.31 (m, 1H), 1.26 (s, 3H), 1.12 (s, 3H), 1.10 (s, 3H);
13C NMR(100MHz,CDCl 3)δ87.5,86.8,85.9,81.3,78.5,77.2,76.2,75.1,68.4,37.4,32.4,30.8,28.9,27.85,27.80,25.8,25.2,23.7,21.3; 13 C NMR (100MHz, CDCl 3 ) δ 87.5, 86.8, 85.9, 81.3, 78.5, 77.2, 76.2, 75.1, 68.4, 37.4, 32.4, 30.8, 28.9, 27.85, 27.80, 25.8, 25.2, 23.7, 21.3;
HRMS(ESI)m/z C 19H 33O 5[M+H] +计算值341.2328,实测值341.2321. HRMS(ESI)m/z C 19 H 33 O 5 [M+H] + calculated value 341.2328, measured value 341.2321.
综合实施例1-9可知,本发明的合成方法可以以高达55%的收率得到具有2个反式稠合的环醚的聚醚,以高达57%的收率得到具有3个反式稠合的环醚的聚醚,以高达40%的收率得到具有4个反式稠合的环醚的聚醚,以高达19%的收率得到含有八元环并具有4个反式稠合的环醚的聚醚,以高达17%的收率得到具有brevenal分子中的反式稠合的7/7/6/7/6五环醚骨架的聚醚。可见本发明提供的由长链的同手性多环氧化合物经一步串联反应合成具有反式稠合多聚环醚骨架结构的聚醚的方法,具有原料可由廉价易得的试剂方便地制备,实验操作简单,反应条件温和,反应快速等优点。From Examples 1-9, it can be seen that the synthesis method of the present invention can obtain a polyether with 2 trans-fused cyclic ethers at a yield of up to 55%, and obtain a polyether with 3 trans-fused cyclic ethers at a yield of up to 57%. The polyether of the cyclic ether is obtained with a yield of up to 40%, and the polyether with 4 trans-fused cyclic ethers is obtained with a yield of up to 19%. It contains an eight-membered ring and has 4 trans-fused The polyether of the cyclic ether is as high as 17% to obtain the polyether with the trans-fused 7/7/6/7/6 pentacyclic ether skeleton in the brevenal molecule. It can be seen that the method for synthesizing a polyether with a trans-fused polycyclic ether skeleton structure from a long-chain homochiral polyepoxy compound through a one-step tandem reaction provided by the present invention has raw materials that can be conveniently prepared from cheap and readily available reagents. The experimental operation is simple, the reaction conditions are mild, and the reaction is fast.
以上描述了本发明优选实施方式,然其并非用以限定本发明。本领域技术人员对在此公开的实施方案可进行并不偏离本发明范畴和精神的改进和变化。The preferred embodiments of the present invention are described above, but they are not intended to limit the present invention. Those skilled in the art can make improvements and changes to the embodiments disclosed herein without departing from the scope and spirit of the present invention.

Claims (10)

  1. 一种式(I)所示的反式稠合多聚环醚化合物的制备方法,其包括如下步骤:在反应介质和含弱配位阴离子的盐的存在下,式(II)所示的同手性多环氧化合物经一步环化反应制备得到式(I)所示的反式稠合多聚环醚化合物;A preparation method of a trans-fused polycyclic ether compound represented by formula (I), which comprises the following steps: in the presence of a reaction medium and a salt containing a weak coordination anion, the same hand represented by formula (II) The polyepoxy compound is prepared by a one-step cyclization reaction to obtain the trans-fused polycyclic ether compound represented by formula (I);
    Figure PCTCN2021099762-appb-100001
    Figure PCTCN2021099762-appb-100001
    其中,在式(I)所示的反式稠合多聚环醚化合物以及式(II)所示的同手性多环氧化合物中:Among them, in the trans-fused polycyclic ether compound represented by formula (I) and the homochiral polyepoxy compound represented by formula (II):
    各个R相同或不同,其独立选自H、C 1-3烷基-或卤代C 1-3烷基-; Each R is the same or different, and is independently selected from H, C 1-3 alkyl- or halogenated C 1-3 alkyl-;
    各个R 1相同或不同,其独立选自H、C 1-10烷基-、C 1-10烷基-O-C 1-10烷基-、C 6-10芳基-C 1-10烷基-O-C 1-10烷基-、卤代C 1-10烷基-; Each R 1 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halogenated C 1-10 alkyl-;
    各个R 2相同或不同,其独立选自H、C 1-10烷基-、C 1-10烷基-O-C 1-10烷基-、C 6-10芳基-C 1-10烷基-O-C 1-10烷基-、卤代C 1-10烷基-;或者R 2在与双键碳原子相连的情况下,则R 2不存在; Each R 2 is the same or different, and is independently selected from H, C 1-10 alkyl-, C 1-10 alkyl-OC 1-10 alkyl-, C 6-10 aryl-C 1-10 alkyl- OC 1-10 alkyl-, halo C 1-10 alkyl-; or when R 2 is connected to a double-bonded carbon atom, then R 2 does not exist;
    各个n相同或不同,其独立选自1、2、3或4;Each n is the same or different, and is independently selected from 1, 2, 3, or 4;
    当n=2或3或4时,在适合的情况下,式(I)的聚醚化合物和式(II)的多环氧化合物中相邻两个碳原子之间任选形成C=C双键,且式(II)的多环氧化合物中的C=C双键位置与作为产物的式(I)的聚醚化合物中的C=C双键位置相对应;When n=2 or 3 or 4, where appropriate, the polyether compound of formula (I) and the polyepoxy compound of formula (II) optionally form a C=C double between adjacent two carbon atoms The position of the C=C double bond in the polyepoxy compound of formula (II) corresponds to the position of the C=C double bond in the polyether compound of formula (I) as the product;
    在式(I)的聚醚化合物以及式(II)的多环氧化合物中,
    Figure PCTCN2021099762-appb-100002
    片段中碳原子可以任 选被以下基团取代:H、OH、C 1-4烷基-或卤代C 1-4烷基-;
    In the polyether compound of formula (I) and the polyepoxy compound of formula (II),
    Figure PCTCN2021099762-appb-100002
    The carbon atoms in the fragments can be optionally substituted by the following groups: H, OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-;
    R 3为H或对酸敏感的羟基保护基; R 3 is H or an acid-sensitive hydroxyl protecting group;
    在式(I)所示的反式稠合多聚环醚化合物中,
    Figure PCTCN2021099762-appb-100003
    部分表示x片段和y片段依次重复出现的结构,整个式(I)分子中x片段数目Nx≥1,y片段数目Ny≥0,1≤Nx+Ny≤20;
    In the trans-fused polycyclic ether compound represented by formula (I),
    Figure PCTCN2021099762-appb-100003
    Part represents the structure of x fragments and y fragments appearing in sequence, the number of x fragments in the molecule of formula (I) is Nx≥1, the number of y fragments is Ny≥0, 1≤Nx+Ny≤20;
    在式(II)所示的同手性多环氧化合物中,
    Figure PCTCN2021099762-appb-100004
    部分表示u片段和v片段依次重复出现的结构,整个式(II)分子中u片段数目Nu≥1,v片段数目Nv≥0,1≤Nu+Nv≤20。
    In the homochiral polyepoxy compound represented by formula (II),
    Figure PCTCN2021099762-appb-100004
    The part represents the structure where u fragment and v fragment appear successively, the number of u fragments in the whole formula (II) molecule is Nu≥1, the number of v fragments is Nv≥0, and 1≤Nu+Nv≤20.
  2. 如权利要求1所述的制备方法,其特征在于,式(I)所示的反式稠合多聚环醚化合物和式(II)所示的多环氧化合物结构如以下方案1-11中任一方案所述,The preparation method according to claim 1, wherein the structures of the trans-fused polycyclic ether compound represented by formula (I) and the polyepoxy compound represented by formula (II) are as shown in the following schemes 1-11 As described in any plan,
    方案1:plan 1:
    Figure PCTCN2021099762-appb-100005
    Figure PCTCN2021099762-appb-100005
    方案2:Scenario 2:
    Figure PCTCN2021099762-appb-100006
    Figure PCTCN2021099762-appb-100006
    方案3:Option 3:
    Figure PCTCN2021099762-appb-100007
    Figure PCTCN2021099762-appb-100007
    方案4:Option 4:
    Figure PCTCN2021099762-appb-100008
    Figure PCTCN2021099762-appb-100008
    方案5:Option 5:
    Figure PCTCN2021099762-appb-100009
    Figure PCTCN2021099762-appb-100009
    方案6:Option 6:
    Figure PCTCN2021099762-appb-100010
    Figure PCTCN2021099762-appb-100010
    方案7:Scheme 7:
    Figure PCTCN2021099762-appb-100011
    Figure PCTCN2021099762-appb-100011
    方案8:Option 8:
    Figure PCTCN2021099762-appb-100012
    Figure PCTCN2021099762-appb-100012
    方案9:Scheme 9:
    Figure PCTCN2021099762-appb-100013
    Figure PCTCN2021099762-appb-100013
    方案10Scheme 10
    Figure PCTCN2021099762-appb-100014
    Figure PCTCN2021099762-appb-100014
    方案11:Option 11:
    Figure PCTCN2021099762-appb-100015
    Figure PCTCN2021099762-appb-100015
  3. 如权利要求1或2所述的制备方法,其特征在于,所述对酸敏感的羟基保护基为醚类保护基或硅醚保护基;所述醚类保护基例如2-四氢吡喃基;所述硅醚保护基例如三甲基硅基或三乙基硅基;所述对酸敏感的羟基保护基优选为2-四氢吡喃基或三甲基硅基,进一步优选2-四氢吡喃基;The preparation method according to claim 1 or 2, wherein the acid-sensitive hydroxyl protecting group is an ether protecting group or a silyl ether protecting group; the ether protecting group is, for example, 2-tetrahydropyranyl The silyl ether protecting group is for example trimethylsilyl or triethylsilyl; the acid-sensitive hydroxyl protecting group is preferably 2-tetrahydropyranyl or trimethylsilyl, more preferably 2-tetra Hydropyranyl;
    和/或,与&标记的碳原子连接的
    Figure PCTCN2021099762-appb-100016
    结构为
    Figure PCTCN2021099762-appb-100017
    Figure PCTCN2021099762-appb-100018
    Figure PCTCN2021099762-appb-100019
    其中a端与环氧基团连接,b端与&标记的碳原子连接;其他
    Figure PCTCN2021099762-appb-100020
    结构相同或不同,其独立地为
    Figure PCTCN2021099762-appb-100021
    Figure PCTCN2021099762-appb-100022
    c端与左侧基团连接,d端与右侧基团连接;上述
    Figure PCTCN2021099762-appb-100023
    结构中的每一个氢原子独立地任选被R 4取代;R 4独立地为OH、C 1-4烷基-或卤代C 1-4烷基-,优选C 1-3烷基-,特别优选甲基;
    And/or, attached to the & marked carbon atom
    Figure PCTCN2021099762-appb-100016
    Structure is
    Figure PCTCN2021099762-appb-100017
    Figure PCTCN2021099762-appb-100018
    Figure PCTCN2021099762-appb-100019
    The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
    Figure PCTCN2021099762-appb-100020
    The structure is the same or different, which are independently
    Figure PCTCN2021099762-appb-100021
    Figure PCTCN2021099762-appb-100022
    The c terminal is connected to the left group, and the d terminal is connected to the right group;
    Figure PCTCN2021099762-appb-100023
    Each hydrogen atom in the structure is independently optionally substituted by R 4 ; R 4 is independently OH, C 1-4 alkyl- or halogenated C 1-4 alkyl-, preferably C 1-3 alkyl-, Particularly preferred is methyl;
    和/或,各个R相同或不同,其独立选自H、C 1-3烷基-;更优选H、甲基、乙基、丙基、异丙基;最优选H、甲基; And/or, each R is the same or different, and is independently selected from H, C 1-3 alkyl-; more preferably H, methyl, ethyl, propyl, isopropyl; most preferably H, methyl;
    和/或,各个R 1相同或不同,其独立选自H、C 1-6烷基-、C 1-6烷基-O-C 1-6烷基-、卤代C 1-6烷基-;优选H、C 1-3烷基-、C 1-3烷基-O-C 1-3烷基-、卤代C 1-3烷基-;更优选H、甲基、乙基、丙基、异丙基;最优选H、甲基;或者,R 1在与双键碳原子相连的情况下,则R 1不存在; And/or, each R 1 is the same or different, and is independently selected from H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, halo C 1-6 alkyl-; Preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; more preferably H, methyl, ethyl, propyl, iso Propyl; most preferably H, methyl; or, when R 1 is connected to a double-bonded carbon atom, then R 1 does not exist;
    和/或,各个R 2相同或不同,其独立选自H、C 1-6烷基-、C 1-6烷基-O-C 1-6烷基-、卤代C 1-6烷基-;优选H、C 1-3烷基-、C 1-3烷基-O-C 1-3烷基-、卤代C 1-3烷基-;更优选H、甲基、乙基、丙基、异丙基;最优选H、甲基;或者,R 2在与双键碳原子相连的情况下,则R 2不存在; And/or, each R 2 is the same or different, and is independently selected from H, C 1-6 alkyl-, C 1-6 alkyl-OC 1-6 alkyl-, halo C 1-6 alkyl-; Preferably H, C 1-3 alkyl-, C 1-3 alkyl-OC 1-3 alkyl-, halogenated C 1-3 alkyl-; more preferably H, methyl, ethyl, propyl, iso Propyl; most preferably H, methyl; or, when R 2 is connected to a double-bonded carbon atom, then R 2 does not exist;
    和/或,1≤Nx+Ny≤15;优选1≤Nx+Ny≤10;更优选1≤Nx+Ny≤8,例如1、2、3、4、5、6、7或8;最优选1≤Nx+Ny≤4;1≤Nu+Nv≤15;优选1≤Nu+Nv≤10;更优选1≤Nu+Nv≤8,例如1、2、3、4、5、6、7或8;最优选1≤Nu+Nv≤4。And/or, 1≤Nx+Ny≤15; preferably 1≤Nx+Ny≤10; more preferably 1≤Nx+Ny≤8, such as 1, 2, 3, 4, 5, 6, 7 or 8; most preferably 1≤Nx+Ny≤4; 1≤Nu+Nv≤15; preferably 1≤Nu+Nv≤10; more preferably 1≤Nu+Nv≤8, such as 1, 2, 3, 4, 5, 6, 7 or 8; most preferably 1≤Nu+Nv≤4.
  4. 如权利要求1-3中任一项所述的制备方法,其特征在于,各个n相同或不同,其独立选自1、2或3;The preparation method according to any one of claims 1 to 3, wherein each n is the same or different, and is independently selected from 1, 2 or 3;
    和/或,与*标记的碳原子连接的R和R 1均为甲基; And/or, both R and R 1 attached to the carbon atom marked with * are methyl groups;
    和/或,u、v、x和y片段中的R独立地为H或甲基;And/or, R in the u, v, x and y fragments is independently H or methyl;
    和/或,与&标记的碳原子连接的
    Figure PCTCN2021099762-appb-100024
    结构为
    Figure PCTCN2021099762-appb-100025
    Figure PCTCN2021099762-appb-100026
    其中a端与环氧基团连接,b端与&标记的碳原子连接;其他
    Figure PCTCN2021099762-appb-100027
    结构相同或不同,其独立地为
    Figure PCTCN2021099762-appb-100028
    And/or, attached to the & marked carbon atom
    Figure PCTCN2021099762-appb-100024
    Structure is
    Figure PCTCN2021099762-appb-100025
    Figure PCTCN2021099762-appb-100026
    The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
    Figure PCTCN2021099762-appb-100027
    The structure is the same or different, which are independently
    Figure PCTCN2021099762-appb-100028
    和/或,与&标记的碳原子连接的R 2和R为H,或者,&标记的碳原子上连接有双键时,与&标记的碳原子连接的R 2不存在; And/or, R 2 and R connected to the carbon atom marked with & are H, or, when a double bond is connected to the carbon atom marked with &, R 2 connected to the carbon atom marked with & does not exist;
    和/或,与#标记的碳原子连接的R 2和R是相同的且为H或甲基。 And/or, R 2 and R connected to the carbon atom marked with # are the same and are H or methyl.
  5. 如权利要求1-4中任一项所述的制备方法,其特征在于,式(I)所示的反式稠合多聚环醚化合物和式(II)的多环氧化合物结构如以下方案I-V中任一方案中所述:The preparation method according to any one of claims 1 to 4, wherein the structure of the trans-fused polycyclic ether compound of formula (I) and the polyepoxy compound of formula (II) is as follows As described in any scheme in IV:
    方案I:Scheme I:
    Figure PCTCN2021099762-appb-100029
    Figure PCTCN2021099762-appb-100029
    R、R 1、R 2、R 3、n、
    Figure PCTCN2021099762-appb-100030
    的定义如权利要求1-4中任一项所述;
    R, R 1 , R 2 , R 3 , n,
    Figure PCTCN2021099762-appb-100030
    The definition of is as described in any one of claims 1-4;
    方案II:Scheme II:
    Figure PCTCN2021099762-appb-100031
    Figure PCTCN2021099762-appb-100031
    R、R 1、R 2、R 3、n、
    Figure PCTCN2021099762-appb-100032
    的定义如权利要求1-4中任一项所述;
    R, R 1 , R 2 , R 3 , n,
    Figure PCTCN2021099762-appb-100032
    The definition of is as described in any one of claims 1-4;
    方案III:Scheme III:
    Figure PCTCN2021099762-appb-100033
    Figure PCTCN2021099762-appb-100033
    R、R 1、R 2、R 3、n、
    Figure PCTCN2021099762-appb-100034
    的定义如权利要求1-4中任一项所述;
    R, R 1 , R 2 , R 3 , n,
    Figure PCTCN2021099762-appb-100034
    The definition of is as described in any one of claims 1-4;
    方案IV:Scheme IV:
    Figure PCTCN2021099762-appb-100035
    Figure PCTCN2021099762-appb-100035
    R、R 1、R 2、R 3、n、
    Figure PCTCN2021099762-appb-100036
    的定义如权利要求1-4中任一项所述;
    R, R 1 , R 2 , R 3 , n,
    Figure PCTCN2021099762-appb-100036
    The definition of is as described in any one of claims 1-4;
    方案V:Scheme V:
    Figure PCTCN2021099762-appb-100037
    Figure PCTCN2021099762-appb-100037
    R、R 1、R 2、R 3、n、
    Figure PCTCN2021099762-appb-100038
    的定义如权利要求1-4中任一项所述。
    R, R 1 , R 2 , R 3 , n,
    Figure PCTCN2021099762-appb-100038
    The definition of is as described in any one of claims 1-4.
  6. 如权利要求1-5中任一项所述的制备方法,其特征在于,式(I)所示的反式稠合多聚环醚化合物和式(II)所示的多环氧化合物结构如下:The preparation method according to any one of claims 1 to 5, wherein the structures of the trans-fused polycyclic ether compound represented by formula (I) and the polyepoxy compound represented by formula (II) are as follows :
    Figure PCTCN2021099762-appb-100039
    Figure PCTCN2021099762-appb-100039
    u、v、x和y片段中的R独立地为H或甲基;R in the u, v, x and y fragments is independently H or methyl;
    与&标记的碳原子连接的
    Figure PCTCN2021099762-appb-100040
    结构为
    Figure PCTCN2021099762-appb-100041
    Figure PCTCN2021099762-appb-100042
    其中a端与环氧基团连接,b端与&标记的碳原子连接;其他
    Figure PCTCN2021099762-appb-100043
    结构相同或不同,其独立地为
    Figure PCTCN2021099762-appb-100044
    Connected to the & marked carbon atom
    Figure PCTCN2021099762-appb-100040
    Structure is
    Figure PCTCN2021099762-appb-100041
    Figure PCTCN2021099762-appb-100042
    The a terminal is connected to the epoxy group, and the b terminal is connected to the carbon atom marked with &; others
    Figure PCTCN2021099762-appb-100043
    The structure is the same or different, which are independently
    Figure PCTCN2021099762-appb-100044
    与#标记的碳原子连接的R 2和R是相同的且为H或甲基; R 2 and R connected to the carbon atom marked with # are the same and are H or methyl;
    与&标记的碳原子连接的R 2为H,或者,&标记的碳原子上连接有双键时,则与&标记的碳原子连接的R 2不存在。 R 2 connected to the carbon atom labeled & is H, or when a double bond is connected to the carbon atom labeled &, R 2 connected to the carbon atom labeled & does not exist.
  7. 如权利要求1-6中任一项所述的制备方法,其特征在于,式(I)所示的反式稠合多聚环醚化合物和式(II)所示的多环氧化合物结构如下任一组所定义:The preparation method according to any one of claims 1-6, wherein the structures of the trans-fused polycyclic ether compound represented by formula (I) and the polyepoxy compound represented by formula (II) are as follows Defined by any group:
    Figure PCTCN2021099762-appb-100045
    Figure PCTCN2021099762-appb-100045
    Figure PCTCN2021099762-appb-100046
    Figure PCTCN2021099762-appb-100046
  8. 如权利要求1-7中任一项所述的制备方法,其特征在于,所述反应介质选自被一个或多个卤素取代的C 1-10烷基醇或其与其他溶剂的混合溶剂,所述其他溶剂选自一个或多个卤素取代的C 1-10烷烃、任选被一个或多个卤素取代的C 1-10醚或环醚、任性被一个或多个卤素取代的C 1-10酯; The preparation method according to any one of claims 1-7, wherein the reaction medium is selected from a C 1-10 alkyl alcohol substituted by one or more halogens or a mixed solvent with other solvents, The other solvent is selected from C 1-10 alkanes substituted with one or more halogens, C 1-10 ethers or cyclic ethers optionally substituted with one or more halogens, and C 1- substituted optionally by one or more halogens. 10 esters;
    和/或,所述含有弱配位阴离子的盐中阴离子选自含氟的弱配位阴离子;And/or, the anion in the salt containing a weak coordination anion is selected from fluorine-containing weak coordination anions;
    和/或,所述含有弱配位阴离子的盐中阳离子选自季铵离子或季磷离子。And/or, the cation in the salt containing weak coordination anion is selected from quaternary ammonium ion or quaternary phosphorus ion.
  9. 根据权利要求8所述的制备方法,其特征在于,所述一个或多个卤素取代的C 1- 10烷基醇选自被一个或多个卤素取代的C 1-8烷基醇,优选为被一个或多个卤素取代的C 1-6烷基醇,更优选为被一个或多个卤素取代的C 1-4烷基醇,所述卤素选自氟、氯、溴、碘;所述一个或多个卤素取代的C 1-10烷基醇例如三氟甲醇、三氟乙醇、全氟乙醇、三氟丙醇、六氟丙醇、全氟丙醇、三氟丁醇、六氟丁醇、全氟丁醇、三氟戊醇、六氟戊醇、全氟戊醇、三氟己醇、六氟己醇、全氟己醇; The production method according to claim 8, wherein said one or more halogen substituted C 1- 10 alkyl alcohol is selected from one or more halogen substituted C 1-8 alkyl alcohol, preferably C 1-6 alkyl alcohol substituted by one or more halogens , more preferably C 1-4 alkyl alcohol substituted by one or more halogens, the halogen being selected from fluorine, chlorine, bromine, and iodine; One or more halogen-substituted C 1-10 alkyl alcohols such as trifluoromethanol, trifluoroethanol, perfluoroethanol, trifluoropropanol, hexafluoropropanol, perfluoropropanol, trifluorobutanol, hexafluorobutanol Alcohol, perfluorobutanol, trifluoropentanol, hexafluoropentanol, perfluoropentanol, trifluorohexanol, hexafluorohexanol, perfluorohexanol;
    和/或,所述其他溶剂选自氯仿、二氯甲烷、1,2-二氯乙烷、1,1-二氯乙烷乙醚、四氢呋喃、1,4-二氧六环;And/or, the other solvent is selected from chloroform, dichloromethane, 1,2-dichloroethane, 1,1-dichloroethane ethyl ether, tetrahydrofuran, 1,4-dioxane;
    和/或,所述含有弱配位阴离子的盐的阴离子选自四氟硼酸阴离子、六氟磷酸阴离子、六氟锑酸阴离子、三氟甲磺酸阴离子、四[3,5-双(三氟甲基)苯基]硼酸阴离子、四(五氟苯基)硼酸阴离子;优选四氟硼酸阴离子、六氟磷酸阴离子;最优选四氟硼酸阴离子;And/or, the anion of the salt containing weak coordination anion is selected from the group consisting of tetrafluoroborate anion, hexafluorophosphate anion, hexafluoroantimonate anion, trifluoromethanesulfonic acid anion, tetra[3,5-bis(trifluoro (Methyl) phenyl] borate anion, tetrakis (pentafluorophenyl) borate anion; preferably tetrafluoroborate anion, hexafluorophosphate anion; most preferably tetrafluoroborate anion;
    和/或,所述含有弱配位阴离子的盐的阳离子选自四甲基铵离子(Me 4N +)、四乙基铵离子(Et 4N +)、四正丁基铵离子((n-Bu) 4N +)、四苯基季磷离子(Ph 4P +)、1-丁基-3-甲基咪唑季铵离子([BMIM])、1-乙基-3-甲基咪唑季铵离子([EMIM])、1-己基-3-甲基咪唑季铵离子([HMIM]);优选1-丁基-3-甲基咪唑季铵离子([BMIM])、1-乙基-3-甲基咪唑季铵离子([EMIM]);更优选1-乙基-3-甲基咪唑季铵离子([EMIM])。 And/or, the cation of the salt containing weak coordination anion is selected from the group consisting of tetramethylammonium ion (Me 4 N + ), tetraethylammonium ion (Et 4 N + ), tetra-n-butylammonium ion ((n -Bu) 4 N + ), tetraphenyl quaternary phosphate ion (Ph 4 P + ), 1-butyl-3-methylimidazole quaternary ammonium ion ([BMIM]), 1-ethyl-3-methylimidazole Quaternary ammonium ion ([EMIM]), 1-hexyl-3-methylimidazole quaternary ammonium ion ([HMIM]); preferably 1-butyl-3-methylimidazole quaternary ammonium ion ([BMIM]), 1-ethyl 3-methylimidazole quaternary ammonium ion ([EMIM]); more preferably 1-ethyl-3-methylimidazole quaternary ammonium ion ([EMIM]).
  10. 根据权利要求9所述的制备方法,其特征在于,所述反应介质为三氟甲醇,三氟乙醇、全氟乙醇、三氟丙醇、六氟丙醇、全氟丙醇、三氟丁醇、六氟丁醇、全氟丁醇、三氟戊醇、六氟戊醇、全氟戊醇、三氟己醇、六氟己醇、全氟己醇;优选为2,2,2-三氟乙醇、1,1,1,3,3,3-六氟-2-丙醇、全氟叔丁醇,更优选为全氟叔丁醇;The preparation method according to claim 9, wherein the reaction medium is trifluoromethanol, trifluoroethanol, perfluoroethanol, trifluoropropanol, hexafluoropropanol, perfluoropropanol, trifluorobutanol , Hexafluorobutanol, perfluorobutanol, trifluoropentanol, hexafluoropentanol, perfluoropentanol, trifluorohexanol, hexafluorohexanol, perfluorohexanol; preferably 2,2,2-tri Fluoroethanol, 1,1,1,3,3,3-hexafluoro-2-propanol, perfluoro-tert-butanol, more preferably perfluoro-tert-butanol;
    和/或,所述含有弱配位阴离子的盐的阴离子选自:[BMIM]BF 4,[BMIM]PF 6,[EMIM]BF 4,[EMIM]PF 6,[HMIM]BF 4或[HMIM]PF 6;优选[BMIM]BF 4、[EMIM]BF 4、[HMIM]BF 4;更优选[EMIM]BF 4And/or, the anion of the weakly coordinated anion-containing salt is selected from: [BMIM]BF 4 , [BMIM]PF 6 , [EMIM]BF 4 , [EMIM]PF 6 , [HMIM]BF 4 or [HMIM ]PF 6 ; preferably [BMIM]BF 4 , [EMIM]BF 4 , [HMIM]BF 4 ; more preferably [EMIM]BF 4 .
PCT/CN2021/099762 2020-06-12 2021-06-11 Method for one-step preparation of polyether having trans-fused polycyclic ether framework structure WO2021249545A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010532858.8A CN113801128A (en) 2020-06-12 2020-06-12 Method for preparing polyether with trans-fused polycyclic ether skeleton structure by one-step method
CN202010532858.8 2020-06-12

Publications (1)

Publication Number Publication Date
WO2021249545A1 true WO2021249545A1 (en) 2021-12-16

Family

ID=78846917

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/099762 WO2021249545A1 (en) 2020-06-12 2021-06-11 Method for one-step preparation of polyether having trans-fused polycyclic ether framework structure

Country Status (2)

Country Link
CN (1) CN113801128A (en)
WO (1) WO2021249545A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1878776A (en) * 2003-09-19 2006-12-13 北卡罗来纳威尔明顿大学 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases
CN1882593A (en) * 2003-09-19 2006-12-20 北卡罗来纳威尔明顿大学 Fused pentacyclic polyethers
US20070111318A1 (en) * 2003-11-28 2007-05-17 Hitoshi Ishida Brexetoxin derivative, production process thereof and method for detecting shellfish neurotoxin using same
CN101921280A (en) * 2009-06-13 2010-12-22 烟台海岸带可持续发展研究所 Seaweed polyether compound and preparation method and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1878776A (en) * 2003-09-19 2006-12-13 北卡罗来纳威尔明顿大学 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases
CN1882593A (en) * 2003-09-19 2006-12-20 北卡罗来纳威尔明顿大学 Fused pentacyclic polyethers
US20070111318A1 (en) * 2003-11-28 2007-05-17 Hitoshi Ishida Brexetoxin derivative, production process thereof and method for detecting shellfish neurotoxin using same
CN101921280A (en) * 2009-06-13 2010-12-22 烟台海岸带可持续发展研究所 Seaweed polyether compound and preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FRANK E. MCDONALD, FERNANDO BRAVO, XIA WANG, XUDONG WEI, MOTOKI TOGANOH, J. RAMÓN RODRÍGUEZ, BAO DO, WADE A. NEIWERT, KENNETH I. H: "Endo-Oxacyclizations of Polyepoxides: Biomimetic Synthesis of Fused Polycyclic Ethers", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 67, no. 8, 19 February 2002 (2002-02-19), pages 2515 - 2523, XP002995145, ISSN: 0022-3263, DOI: 10.1021/jo0110092 *
IVAN VILOTIJEVIC , TIMOTHY F. JAMISON: "Epoxide-Opening Cascades Promoted by Water", SCIENCE, vol. 317, no. 5842, 31 August 2007 (2007-08-31), US, pages 1189 - 1192, XP055878622, ISSN: 0036-8075, DOI: 10.1126/science.1146421 *
LI FENG‐XING, REN SHU‐JIAN, LI PEI‐FANG, YANG PENG, QU JIN: "An Endo-Selective Epoxide-Opening Cascade for the Fast Assembly of the Polycyclic Core Structure of Marine Ladder Polyethers", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 59, no. 42, 12 October 2020 (2020-10-12), pages 18473 - 18478, XP055878632, ISSN: 1433-7851, DOI: 10.1002/anie.202007980 *

Also Published As

Publication number Publication date
CN113801128A (en) 2021-12-17

Similar Documents

Publication Publication Date Title
AU2014248014A1 (en) Macrolides and methods of their preparation and use
CN104059041B (en) The preparation method of antidiabetic medicine Dapagliflozin intermediate
WO2021249545A1 (en) Method for one-step preparation of polyether having trans-fused polycyclic ether framework structure
Hurtak et al. Synthesis of the ABC substructure of brevenal by sequential exo-mode oxacyclizations of acyclic polyene precursors
CN110683932B (en) Beta-elemene halide and preparation method thereof
CN113061077B (en) Alpha, alpha-dideuteroalcohol compounds, deuterated drugs and preparation method thereof
WO2015067110A1 (en) Ticagrelor intermediate preparation method
Saha et al. Stereoselective synthesis of 6-oxabicyclo [3.2. 1] octene via (3, 5)-oxonium-ene reaction
Adekenov Synthesis of new derivatives of natural guaianolides
CN110872317A (en) Preparation method of antitumor drug molecule (+) -Preussin intermediate
CN101805339B (en) Entecavir compound preparation method
CN109535120A (en) The preparation method of 7- substitution -3,4,4,7- tetrahydro cyclobutane and cumarin -5- ketone
Enamorado et al. A concise synthesis of the Lycopodium alkaloid cermizine D
CN110294708B (en) Preparation method of trifluoroethylselenophenanthridine and 3, 4-dihydroisoquinoline derivatives
CN110684044B (en) Method for preparing Tubulysin key fragment Tuv
Liu et al. Studies toward the total synthesis of cyclodidemniserinol trisulfate. Part II: 3, 5, 7-Trisubstituted 6, 8-dioxabicyclo [3.2. 1] octane core structure construction via I2-mediated deprotection and ring closure tandem reaction
CN114773303B (en) Preparation method of anticancer drug leader lignan Aglacin B
CN113354659B (en) Synthesis of eribulin mesylate
Chu et al. Diverse synthesis of the C ring fragment of bryostatins via Zn/Cu-promoted conjugate addition of α-hydroxy iodide with enone
CN105949131B (en) Pleuromutilin-metronidazole heterozygosis medicine and preparation method thereof
CN104860954B (en) A kind of phenyl ester spiropiperidines or spiropyrrolidines class compound and preparation method thereof
CN111748002B (en) Deoxyglucose modified folic acid derivative and synthesis and application thereof
CN101235044B (en) Method for preparing faropenem daloxate
CN110684036A (en) Method for preparing eribulin mesylate
CN106518886A (en) Preparation of chiral 3-aryl-3-hydroxymethyl-2-indolone compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21822903

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21822903

Country of ref document: EP

Kind code of ref document: A1